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CHAPTER I . 
INTRODUCTION. 
1.1. HISTORICAL NOTE. 
During his work on organophosphorus insecticides, G. 
Schrader synthetized tabun in 1936 and sarin in 1939. Be-
cause of the high mammalian toxicity of both compounds, 
now commonly known as nerve agents, their possible use as 
chemical warfare agents was studied at the Heeres Gas-
schütz Laboratorien at Spandau (Berlin) and some work on 
the pharmacology of sarin was done at Heidelberg by R. 
Kuhn. In the context of this pharmacological research, 
soman was synthesized as a sarin analogue at the end of 
1944 (Robinson, 1971). Later the compound proved to be 
more toxic than tabun or sarin and, in addition, soman 
intoxication appeared to be more resistent to therapy. 
1.2. CHEMICAL PROPERTIES OF SOMAN. 
1.2.1. Structure. 
Soman (1,2,2-trimethylpropyl methylphosphonofluorida-
te or pinacolyl methylphosphonofluoridate) is a di-ester 
of methylphosphonic acid, containing an anhydric ester 
bond with fluorine and a pinacolyl ester bond (Figure 
1-1). 
F 4 / 0 
СНзΗ ρ* •  
НзС-С-С*-0 сн, 3
 ι ι 
СНз ^•'з 
Figure I-I. : 1,2,2-trimethylpropylmethylphosphonofluori-
date (soman). The asymmetric centra are designated with 
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Figure 1-2. : Four stereoisomers of soman. Absolute con­
figuration according to Cahn &t a-l (1966). (1) Denotes 
mirror plane for the configuration at phosphorus. (2) De­
notes mirror plane for the configuration at the o-carbon 
of the pinacolyl moiety. 
The compound has two asymmetric centres, one at phos­
phorus and one at the α-carbon of the pinacolyl moiety. 
Consequently soman consists of four stereoisomers (Figure 
1-2) : two pairs of antipodes (not-superimposable mirror 
images) and two pairs of diastereoisomers (not-superimpo­
sable; no mirror images). The diastereoisomers are also 
epimers since they differ in the configuration of only one 
asymmetric centre (Mislow, 1965). Diastereoisomers have 
dissimilar intramolecular group distances; they conse­
quently differ in intramolecular group interactions and 
thereby in thermodynamic properties. Isomers that differ 
at an asymmetric centre show different optical rotations. 
Their relative configuration can be attributed accor­
dingly. By convention optical rotation is indicated by 
writing a "plus" (dextrorotatory) or a "minus" (levorota-
tory) after the symbol of the asymmetric centre. The four 
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isomers of soman can thus be written as C(-)P(+), 
C(-)P(-), C(+)P(+) and C(+)P(-), in which С stands for the 
asymmetric carbon at the pinacolyl moiety and Ρ for the 
asymmetry around the phosphorus atom. 
The absolute configuration is designated according to 
the nomenclature described by Cahn at al (1966) and is 
obtained by direct structure identification or by chemical 
correlation. For the pinacolyl moiety in soman, the 
levorotatory isomer is associated with the absolute 
R-configuration (Jacobus e-i aA , 1965). The absolute 
configuration at the phosphorus is, formally, still 
unknown (Benschop, 1975). The isomers of soman are 
therefore indicated according to their relative confi­
guration. 
To isolate the four isomers of soman the epimeric 
pairs C( + )P(±) and C(-)P(±) v.ere obtained by synthesis 
from optically resolved pinacolyl alcohol. Further 
resolution was accomplished by a stereoselective 
hydrolysis of the P( + )-isoniers in rabbit serum and a 
stereoselective inhibition of a-chymotrypsin with the 
P(-)-isomers (Benschop et al, 1984a). 
C(+)P(±) C(-)P(±) 
rabbit α-chymo- rabbit a-chymo-
serum trypsin serum trypsin 
I 
C(+)P(-) C(+)P(+) C(-)P(-) C(-)P(+) 
Notation : The mixture of the stereoisomers, as syntheti-
zed from racemic pinacolyl alcohol, will be designated as 
C(±)P(±)-soman whereas the epimeric pairs derived from 
(+)- and (-)-pinacolyl alcohol are indicated as C(+)P(±)-
and C(-)P(±)-soman. 
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1.2.2. Reactivity. 
The chemical reactivity of soman is mainly due to the 
polarity of the phosphoryl moiety, based on the different 
electronegativity between phosphorus and oxygen. The 
phosphoryl bond can be seen as being composed of a dative 
covalent bond (α-bond) with p^-dn assistance, leading to a 
partial double bond character, allowing the backflow of 
electrons. Thereby the polarity is reduced as compared 
with a (theoretically) pure dative Ρ + 0 bond (Hudson, 
1965). The polarity of the phosphoryl group is further 
influenced by the nature of the substituents at the 
phosphorus. The electron-donating properties of the 
methyl- and pinacolylgroup tend to decrease the polarity. 
The fluorine, due to its high electronegativity, tends to 
increase the polarity, however, through a pn-dir backbon-
ding (Van Wazer, 1958) this effect is weakened. The 
importance of bimolecular nucleophilic reactions (SN2) at 
the phosphorus, with fluorine as a leaving group, is a 
direct result of the phosphoryl polarity. Too fast 
splitting of the phosphorus-fluorine bond, however, is 
prevented by the existing backbonding. 
F CH 
i$g'/ 3 H CH, 
. 0 ^ O r C r C = CH, 
6
 ti tl 
CH3 CH, 
Figure 1-3. : Polarisation and electronic shifts in 1,2,2-
trimethylpropyl methylphosphonofluoridate. Electronic 
shifts are shown by straight arrows. Significant pir-dir 
bonding is shown by curved arrows. The resulting polari­
sation of the phosphoryl bond is indicated by partial 
charges. 
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Another important reaction that may occur under cer­
tain circumstances is a monomolecular nucleophilic substi­
tution, catalyzed oy electrophile, with splitting of the 
alkyl group {v^de. uxpw. , aging reaction]. Nucleophilic 
substitution at the α-carbon atom of the pinacolyl moiety 
is almost impossible, due to the steric hindrance presen­
ted by the t-butyl group. 
1.3. TOXICITY OF SOMAN. 
1.3.1. General. 
The acute toxicity of pinacolyl methylphosphonofluo-
ridate is brought about primarily by its ability to 
inhibit the enzyme acetylcholinesterase. This enzyme, 
being responsible for the rapid hydrolysis of the 
neurotransmitter acetylcholine, plays an important role in 
the regulation of transmission of nerve impulses. The 
presence of cholinergic synapses both in the peripheral 
nervous system, and in the central nervous system 
explains the characteristic symptoms of a nerve agent 
poisoning. These are analogous to the symptoms of a severe 
poisoning by organophosphorus insecticides (Grob, 1963). 
At low doses the effects are situated mainly in the 
autonomic systems : miosis, hypersalivation, enhanced 
gastrointestinal motility and bradycardia. At higher 
doses the effects at the myoneural endplate, such as 
muscle fasciculations, muscle weakness and paralysis 
predominate the clinical picture. At still higher doses 
central effects, convulsions, coma and disregulation of 
the respiratory centre occur. In lethal intoxications, 
the latter effect, usually, is the cause of death. 
1.3.2. Biochemical background of poisoning by anticholi­
nesterase compounds and general therapeutic princi­
ples. 
The inhibition of the enzyme acetylcholinesterase is 
the basic biochemical reaction of an organophosphorus 
intoxication. Phosphonylation of the enzyme by the nerve 
agent yields a covalent bond between the nerve agent and 
the enzyme. Figure 1-4 indicates the possible fates of 
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the phosphonylated enzyme : spontaneous reactivation indu­
ced by water (almost negligible), reactivation by oximes, 
which is possible for some organophosphorus nerve agents, 
and aging, -L.e. splitting at the oxygen-alkyl bond. 
R</ 4CH, 
H- --H-O r 
>> ч I ; 
Η,Ο 
о I си, 
— ^ ч 
Of- 4 о н-о о 
сн,
 и
 ^Ч* 9 / Р ч ¿H, H RO СН, 
УЧ-"Н-у. 
Figure 1-4. : Fate of alkyl methylphosphonylated Cholines­
terase. (1) Spontaneous reactivation with formation of 
alkyl methylphosphonic acid; (2) aging by splitting off of 
alkyl group; (3) reactivation induced by е.д.. oximes. 
Reactivation by oximes is the cornerstone of modern 
causal therapy against nerve agent intoxication (Wilson 
and Froede, 1971), but specific problems arise when reac­
tivation therapy is applied in soman poisoning ( vide in-
pia). Symptomatic treatment on the other hand is based on 
the administration of atropine. This compound is active 
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at the muscarinic receptors, protecting them by a mecha-
nism of competitive inhibition against the action of 
non-hydrolyzed acetylcliolir,e. This explains its effect at 
the autonomic system; in addition an anticonvulsant may be 
part of the symptomatic therapy. Finally, the prophylac-
tic administration of carbamates, Cholinesterase 
inhibiting compounds that show considerable spontaneous 
reactivation, may result in the binding of a part of the 
acetylcholinesterase pool, thereby protecting the enzyme 
against irreversible phosphonylation by the nerve agent. 
1.3.3. Specific characteristics of the intoxication by 
soman. 
1.3.3.1. Rapid aging and oxi me resistance. 
Aging is a dealkylation of the phosphonylated acetyl-
cholinesterase at the covalently bound phosphorus (Berends 
QX a-L , 1959). This reaction occurs spontaneously. The 
rates of this dealkylation show large differences for ihe 
various organophosphace inhibited enzymes, depending on 
che organophosphate as well as on the source of the enzyme 
(Ligtenstein, 1984). Soman-inhibited enzymes show 
particularly rapid aging rates. This has also been shown 
to be the case of enzymes of human source (De Jong and 
Kossen, 1985). Oxime therapy, therefore, must, after 
exposure, be initiated extremely rapidly. Fleisher and 
Harris (1963) and Benschop and Keijer (1966) presented 
data giving strong evidence that the rate-determining step 
consists of the unimoiecular fission of the C-0 bond in 
the alkoxy group. The aging-mechanism of soman-inactiva-
ted electric eel Cholinesterase was shown to proceed 
according to a unimoiecular nucleophilic substitution 
(SN1) involving a carbonium ion mechanism (Michel eí a-¿, 
1967) : 
0 H CH 0 _ H СН 
i" i l 3 і ^ ι + ι 
ChE - Ρ - 0 - С - С - СН * ChE - Ρ - 0 + С - С - СН 
1 I I 3 I | | 3 
СН, СН, СН, СН, СН, СН, 
3 3 3 3 3 3 
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The negative charge at phosphorus r.iay ¡зе stabilized 
by resonance between ιwo oxygen atoms, inhibiting the nu-
cleophilic altack of an охі.тіе function at the phosphorus, 
tnus renaering reactivation viriually impossible. The 
carDonium ion will react further leading to a mixture of 
alcohols, by reacción wich water, and to the formation of 
alkenes, by splitting off of H+. Aging of sonian-inhiûited 
acetylcholinesterase was shown to be a stereospecific pro-
cess (Keijer and 'Jolring, 1969). Also the inhibition and 
reactivation of human erythrocyte and brain ace-
tylcholinesterase by soman were reported to be 
stereospecific (ue Jong and Kossen, 1935). 
The lack of efficacy of oxime-tnerapy in soman into-
xication, wir.h "classical" oximes such as P2S and Toxogo-
nin, in sorian intoxication has also been attributed pre-
viously :o a general resistance of this particular 
pnospnonylatei enzyme towards oximes. besides steric hin-
Jrance presented oy the pinacolyl moiety a- the phosphony-
la^ed enzyme (Boskovic el α·<!,1968), however, the failure 
of oxime '.nerapy seems largely related to the aging pheno­
menon. Van der fleer and Uolthuis (1965) however showed 
that the soman-phosphonylated enzyme can be reactivated at 
on appreciable rate, even with "classical' oximes, wnen 
the uxime concentration is increased. Since such nigh 
oxime concentrations are difficult to obtain ¿л VIVO , 
reactivation can only ce achieved witn a new generation of 
oxii.ies. The successful application of such oximes, 
allowing reactivation of soman in rodents ('..'olthuis and 
Kepner, 197^) snowed that resistance to oxime reactivation 
is not a general property of acetylcholinesterase 
phosphonylatea by soman out that the outcome of 
therapeutical intervention with these new oximes is the 
ultimate result of a competition between aging and 
reactivation. This new generation of oximes that is pro­
mising for an effective causal therapy against soman poi­
soning was synthesized by the Hagedorn group at Freiburg. 
These oximes are known under their code names HI, HS and 
HUG. Λ study of the neuromuscular transmission in isola­
ted preparations of striated muscle (Wolthuis et ai , 
1981b), showed that large differences exist in reac­
tivating potency between various species and for various 
oximes. More in particular the human preparation remains 
insufficiently reactivatable even with the new oximes. 
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This may, to a large extent, be attributable to a rapid 
aging of the inhibited human enzymes. 
1.3.3.2. Effect on the central nervous system. 
Already at soman concentrations that only have a 
slight effect on the neuromuscular transmission in the 
diaphragm the respiratory volume is considerebly reduced 
(Meeter and Wol thuis, 1963). The rapid passage of soman 
through the blood-brain barrier was recently confirmed by 
Reynolds eX al (1985) and Kadar &,' α-ί (1985) who analyzed 
intact soman in brain tissue within minutes following the 
intravenous administration of \ Hi-soman in mice. 
1.3.3.3. The problem of a soman 'depot'. 
Qrganophosphorus insecticides, like paratm'on, may 
persist in the body for several days after a severe into­
xication (Boelcke e-c al, 1970, Braeckman eA al, 1983). In 
contrast it was generally accepted that organophosphorus 
nerve agents disappear very rapidly from the body after a 
"hit and run" attack on acetylcholinesterase. Wol thuis <гі 
al (1981a), however, found, after administration of б χ 
LD50 of soman to anaesthetized, atropinized rats, that up 
until over 75 minutes after administration of soman, in­
jected acetylcholinesterase was immediately inhibited. 
They attributed this phenomenon to the presence of soman 
stored in a 'depot' where the agent is protected against 
degradation and from which it can return gradually back 
into the blood. Using the same method, Benschop e-¿ al 
(1981a) showed that the anticholinesterase activity was 
present even more than two hours after intoxication with S 
χ LÜ5U and that a non- toxic soman-simulator, possessing a 
very similar structure but no adequate leaving group, 
interacted with the 'depot'. The attribution of 'depot'-
characteristics to plasma aliesterase (Clement, 1982) is 
not correct since soman is covalently linked to aliestera-
se and not soman but pinacolyl methylphosphonic acid is 
formed as a consequence of dephosphonylation of aliestera-
se at physiological pH (Christen &l ai, 1967; De Jong and 
Van Dijk, 1984). Such a 'depot' however, with specific 
binding sites, does not have to be identified necessarily 
within specific organs, from the pharmacokinetic point of 
view, this should be compatible with a saturable non-
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linear tissue binding model (Wagner, 1975). 
1.4. BIODEGRADATION OF SOMAN. 
Biodegradation is that series of processes by which 
living systems or tissues originating from living systems 
render xenobiotic chemicals less noxious to the environ­
ment. 
An organophosphorus compound requires a specific 
structure, together with a good leaving group in order to 
exhibit affinity and reactivity towards Cholinesterase 
(O'Brien, 1971). Cleavage of one of the oonds to phospho­
rus and suostitution of the leaving group will result in 
an viportant cnange in structure, generally leading to a 
decreased reactivity and hence detoxification. 
Bond cleavage of alkyl methylphosphonofluoridates is 
theoretically possible at four sites. 
(2) (3) (4) 
+ 0 » * 
II 
F - Ρ - 0 - R 
m* ι 
с н 3 
The P-CH bond (1) has a remarkable stability and is 
noL split, even after exhaustive іл V-LVO hydrolysis (Ver-
weij е./ (.U, 1979). To our knowledge no reports exist that 
indicate the cleavage of the P-CH bond by mammalian sys­
tems. 
The anhydric ester bond (2) can easily be split as 
F , which is a good leaving group in spite of existing 
backbond!ng to the phosphorus. Hydrolysis by enzymatic 
processes has been reported for soman. The resulting 
alkyl methylphosphonic acid has a pK of 2.45 (Harris e-t al, 
1964), which at ohysiological pH will give an essentially 
ionic compound. 
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Alkyl methylphosphonic acids will therefore be more hydro-
phi lie than the parent compound and may undergo rapid re­
nal elimination. In addition their general reactivity 
will decrease due to a reduction in electron deficiency at 
phosphorus which is partially compensated for by the 
negative charge. 
The alkyl ester bond (3) has a higher stability as compa­
red with the anhydric_bond (2) because OR is not as good a 
leaving group as is F . Jn VJ.VO splitting of the alkyl-
ester bond could occur by mixed function oxidase systems 
as shown for diethyl phosphates (Donninger, 1971). 
0
 m
fn 0 0 
и ^
0
 II Il 
( C2 H5 0 )2 р " 0 X -* С Н з С Н + НО - Ρ - ΟΧ 
NADHP ¿с 2н 5 
Cleavage of bond (4) was reported to occur in dimethyl-
phosphates in v^i/w under neutral conditions or acid cata­
lysis (Eto, 1974 - p. 61) : 
0 0 
H O : CH - 0 - Ρ - 0 - CH or H O : CH - 0 - Ρ - 0 - CH 
¿ i ! 3 Ζ 3 ! , 3 
он Η он 
With alkyl methylphosphonofluoridates the splitting of 
bond (4) may occur according to a unimolecular nucleophi-
lic substitution (SN1), catalyzed by electrophile, similar 
to the aging reaction : 
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Identification of metabolic processes other chan the 
reported splitting (¿si vi.vo and иг v-ut/iu ) of the anliydric 
es.er bond, P-F, is difficult because of the low coneen-
trations that are obtained J-n v^vo. No attempt will be 
made in chis thesis to identify metabolic or degradation 
products. 
It is assumed, on the basis of its reactivity and litera­
ture data that the ui wbio degradation of soman will es­
sentially occur at the P-F bond, either as a reaction with 
water (hydrolysis), possibly catalyzed by enzymes, or as a 
reaction with proteins (phosphylation). The expected de­
gradation reactions are summarized in figure 1-5. 
SPONTANEOUS HYDROLYSIS 
CATALYZED HYDROLYSIS 
[ IONS, ALBUMIN, ] 
ENZYMATIC HYDROLYSIS 
[PHOSPHORYLPHOSPHATASE(S)] 
PHOSPHONYLATION 
Figure 1—5. : Biodégradation of soman in serum : possible 
paLhways. 
12 
1.4.1. Spontaneous and catalyzed hydrolysis. 
In biological fluids, which contain much waLer, spon-
laneous nydrolysis is part of che expecced processes. 
This hydrolysis, occuring az the P-F oond, as indicated in 
:he previous paragraphs. May be catalyzed Dy ¡ons or n.ole-
cules. The hydrolysis of sarin was shown to be catalyzed 
oy CI, (Epstein e' cu, 1965); Phosphate ions we.'e repor .ed 
.0 catalyze the hydrolysis of dwnefox iheatn and Casa-
pieri, l'J51), of mipafox iHeath, I'Jol) and of urP iRa.'.ia-
chandran, 1ь)71). A strong catalytic effect of copper ions 
on .he nydrolysis of tiFP was reported by .Jagner-uauregg *>· 
a< ( 1 J 5 5 ) . Cerfontain and Van Aken (1955) reported ca­
talytic effects of several oxo-amons of heavy metals on 
.he hydrolysis of ¡.he saiiie compound. Recently, Benschop 
&< cu (ÌUJ5) found iha. the hydrolysis of soi.ian is cataly-
zed by phosphate ions. The possible influence of alim.ln 
and seruni fracción IV-1 are discussed in the following pa-
ragraphs. 
1.4.2. Enzymatic hydrolysis. 
In oiological .issues one can expect enzyiiiatic acti-
vity for che hydrolysis of ester bonds. Tnis esteracic 
activity can be attriouted to a class of enzymes, called 
ester-hydrolases or este.-ases. On .he basis of their 
reactivity towards certain organophosphorus compounds, che 
esterases presene in serum can be classified m .."iree ca-
tegories (Aldndge, 1953; Ooscerbaan and Jansz, 1965) : Л, 
3 and C. The A-esterases catalyze .ne hydrolysis of orga­
nophosphorus compounds, B-escerases a^e inhibited and 
C-es.erases are indifferen. towai'.'.s organophosphorus Com­
pounds. 
A-es^erases also hydrolyse carboxylic acids ( . · . . „ . 
phenylacetate) and carbamates (Aldridge and Reiner, 1972, 
p. 176). In the literature a variety of A-esterases has 
been described. These enzymes were sometimes named after 
the substrate used in the respective studies e. >. sarja­
se, tabunase, üF?-ase. Augustinsson and iiei.riucirger 
(lfJ54a) termed the enzymes hydrolyzing organophosphorus 
compounds phospnorylphospnacases. íioun.er U963j classi-
fied mammalian pnosphorylphospnai.ases in two categories, 
namely specific esterases (tissue-bound enzymes) that are 
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generally activated by ¡•In*4' and Co+H"\ and non-specific 
(serum) esterases that are inhibited by Mn++ and Co** but 
activated by Sr+* and Ba++. 
The first report of an A-esterase in serum (rabbit) 
was made by Mazur (1946) with DFP as a substrate. In hu-
man serum or plasma paraoxon (Aldridge, 1951), tabun (Au-
gustinsson and Heinibürger, 1954b), DFP (Augustinsson and 
Casida, 1959), sarin (Christen, 1967), and severaj p-ni-
trophenyl phosphonates (Becker and Barbaro, 1964; Skrinja-
ric-Spoljar and Reiner, 1963; Kelly and Butler, 1975) were 
shown to be hydrolyzed enzymatically. Studies with mixed 
substrates, heat inactivation and pH-dependency (Aldridge 
and Reiner, 1972) indicated the existence of at least 
three types of serum A-esterases with some overlapping 
specificity. Efforts were made το attribute specific ac­
tivities to various serum fractions. Paraoxonase activity 
appeared to be localized mainly in serum fraction IV-1 
(Erdös and Boggs, 1961) while fraction V (albumin) hy-
drolyzed preferencia!ly the ethyl p-nitrophenyl ethylphos-
phonate (armine) (Skrinjaric'-Spoljar and Reiner, 1968). 
Fraction VI-2 of bovine plasma was reported to contain 
high sarinase activity (Adie, 1956). In recent literature 
more attention was generally paid to tissue-phospho-
rylphosphatases (<?.#. Hoskin e.¿ α-ί, 1934) with a few ex­
ceptions, e.p. studies by Zech and Zürcher (1974) and La-
badie ?·/ cU (1980). 
Organophosphorus nerve agents generally display an 
asymmetric centre at the phosphorus. It can reasonably be 
expected that esterolytic activity will show stereodiffe-
rentiaiion. A stereoselective effect towards taoun was 
reported by Augustinsson (1957) for hog kidney phosphoryl-
phosphatase, but for human plasma phosphorylphosphatase he 
did not find any stereoselectivity. The stereospecific 
nature of the hydrolysis of sarin in plasma of various 
species, including man, was demonstrated by Christen 
(1967). Furthermore it was shown m a t the P( + )-isomer of 
sarin is much more rapidly hydrolyzed than the P(-)-isomer 
(Christen and Van den Muysenoerg, 1965). The enzymatic 
hydrolysis of soman in rat plasma was proven to be 
stereoselective (Christen, 1967). Benschop e¿ a¿ (1981b) 
showed that the P(+)-isomers were rapidly hydrolyzed. The 
same investigators found a difference in hydrolysis rate 
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between the two P( + )-isoniers. Quantitative aspects of the 
rate difference between the four stereoisomers were also 
reported (De Bisschop ел. al, 1985а). 
1.4.3. Phosphylation. 
B-esterases and possibly other proteins are known to 
be susceptible to phosphylation. This reaction, which co­
vers phosphorylation, phosphonylation and phosphinylation 
(Hudson and Keay, 1960), results in the formation of a co-
valent bond between organophosphorus compound and estera­
se. Phosphylation of B-esterases usually results in inac-
tivation of the enzyme. This indicates that phosphylation 
occurs at the active site of the B-esterases, usually 
containing a serine-hydroxyl moiety (Aldridge and Reiner, 
1972). The formation of a stable covalent bond between 
organophosphorus compounds and acetylcholinesterases 
allowed the use of fluorescent; phosphonate labels in 
measuring equivalent weights and number of active sices 
per molecule (Rosenberry, 1975; Berman я.1 ai , 1985). 
Phosphylation of esterases, however, does not necessarily 
result in inactivation. For chis kind of esterases no 
interference with the active site occurs. In one case 
(stem bromelain) evidence has been presented for a 
phosphylation reaction with tyrosine-residue (Murachi eJ 
al, 1965). 
Some earlier ui V-LVO studies mentioned the occurence 
of phosphylation. dandorf and McNamara (1950) reported in 
the rabbit a high binding capacity of [ P1DFP in kidney, 
lung and liver tissues (0.2 to 1.2 ug/gram of dry tissue). 
Cohen and «arringa (1954) were able to show that a small 
portion (0.5 to 1 ug/gram of plasma nitrogen) of [ P]UFP, 
injected in humans, was irreversibly bound to plasma 
proteins. Ramachandran (1966) found a binding of 3 2 P (in 
the order of ug P/whole organ) by mouso livor esterases 
3 2 
after L.p. administration of Ρ , JFP. Pretreatment with 
atropine or oxiines had no influence on this binding. The 
biodisposition of \ H'DFP in mice was studied by Martin 
(1985); he showed that plasmabound OFP rapidly reached a 
maximum of 2 мд of DFP-equivalents/g tissue and then stea­
dily decreased in time. For sarin, Christen (1967) and 
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Polak and Cohen (1969) showed that the phosphonylated rat 
plasma proteins were identical with aliesterase. This was 
corroborated by the experiments of Boskovic (1979). A 
study of the biodisposition of tritiated soman in mice (25 
pg, ¿..v. ) was done recently by Reynolds e-i1 a-l (1985). 
They showed that the level of irreversibly bound soman in 
plasma remained fairly constant at some 100 pg/ml during 
the first 8 hours after dosing and decreased to a low 
level (< 2Ü pg/mg tissue) after one day. 
Since proteins are involved in phosphylation a stereo-
selective effect can be expected. Keijer and Wolring 
(1969) demonstrated a stereoselective effect in the rate 
of inhibition and aging of bovine erythrocyte acetylcho-
linesterase and of horse plasma butyrylcholinesterase by 
the four isomers of soman. De Jong and Kossen (1985) re-
cently reported on the stereoselectivity of the reactiva-
tion of human brain and erythrocyte acetylcholinesterase 
inhibited by soman. The phosphonylation of hog liver 
aliesterase by C(+)- and C(-)-soman epimers was qualitati-
vely studied by Nordgren e-i ai (1984) and also shown to be 
a stereoselective process. It was found that, towards 
cholinesterases, the C(+)P(-)-isomer showed the highest 
affinity followed by the C(-)P(-); the P(+)-isomers had a 
much lower affinity. For hog liver aliesterase the 
C(-)P(+)-isomer showed a much higher phosphonylation rate 
constant than C(-)P(-)-soinan. Regarding the C(+)-epimers 
a higher affinity was found for C(+)P(-)- than for 
C(+)P(+)-soman. 
1.5. AIM OF THE INVESTIGATIONS. 
In paragraph 1.3.3.3. it is shown that the analysis 
of the fate of soman in experimental animals, studied by 
measuring plasma concentrations in function of time, may 
increase our understanding of toxicologically relevant 
plasma concentrations and may eventually lead to a better 
timing of treatment. The development of a sensitive 
method for the assay of soman in plasma or serum therefore 
is the first aim of the investigations described in this 
work. In this context, stabilisation of soman in bio-
logical fluids is important. From the previous paragraphs 
it can be expected that the degradation of soman in plasma 
or in serum will consist mainly of hydrolysis and phospho-
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nylation. The second aim is to contribute to a better in­
sight, qualitatively as well as quantitatively, into these 
degradation processes and to find suitable methods to 
block them. 
1.6. OUTLINE OF THE EXPERIMENTS. 
Chapter II describes a method developed for the assay 
of soman in serum or plasma. This method is then used to 
study the лл v^tro disappearance of soman in human serum 
or plasma. 
The degradation of soman in serum is described in 
chapter III. Phosphonylation could be blocked by preincu­
bation and the hydrolysis of the four isomers is studied 
starting from C(±)P(±)-soman. The hydrolysis process is 
further investigated in detail in chapter IV, using the 
C(+)P(±)- and C(-)P( ±)-isomers, and includes pH and tempe­
rature dependency as well as inhibition studies. Chapter 
V deals with the stereoselective aspects of phosphonyla­
tion, the determination of the concentration of irreversi­
ble binding sites and their identification. 
In chapter VI the degradation of soman in dog serum 
is studied along the same lines as followed for human se­
rum. The method, developed in chapter II, was improved to 
allow routinely a quantitative determination of picogram 
levels of soman per milliliter of serum. This chapter 
ends by the determination of the plasma-concentration ел-
ші time with some observations on the fate of soman in 
anaesthetized and atropimzed dogs, dosed with 10 χ LD50 
of soman. 
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CHAPTER II. 
QUANTITATIVE DETERMINATION OF SOMAN IN SERUM AND PLASMA. 
ILI. INTRODUCTION. 
The development of highly toxic organophosphorus es-
ters urged the search for adequate detection systems. A 
selective method for the detection of organophosphorus 
warfare agents was presented by Schönemann (1944). The 
method is based on the formation of peroxophosphate or 
peroxophosphonate anions, oxidizing aromatic amines to co-
loured compounds that are measured spectrophotometrically. 
Variations of this method were reported later, using indo-
le and fluorimetry (Gehauf and Goldenson, 1957) or luminol 
and luminescence detection (Goldenson, 1957). The detec-
tion limit is in the range of 0.1 mg/ml to 0.3 pg/ml 
(Lohs, 1962). A modified Schönemann reaction based on 
chemoluminescence detection was reported to give a detec-
tion limit of about 50 ng/ml (Pritsche, 1980). 
Since the inhibixion of B-esterases (Aldridge, 1953) 
is a characteristic property of these organophosphates, it 
seems obvious to use this property to assay them. The 
enzyme and the organophosphate are incubated under well-
defined conditions and the residual esterase activity is 
measured, e.p. by manometric detection of CO production 
in a bicarbonate buffer (Goldstein, 1944), by pH-detection 
of acid production (Michel, 1949), by colorimetry (El Iman 
e¿ α-Ζ, 1961) or by fluorimetry (Guibault and Kramer, 1965) 
of the reaction products. The detection limit of these 
methods is circa 1 ng/ml. 
Measurement of radioactivity using 32P-labeled DFP 
was used for ¿л v^vo toxicokinetic and metabolic studies 
(Jandorf and McNamara, 1950; Ramachandran, 1966). Chris-
ten (1967) used P-labeled sarin to study its enzymatic 
degradation in plasma. A detection limit was not given 
but the use of Η-labeled DFP recently allowed Martin 
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(1985) to quantify at a level of pg/ml. 
A mouse monoclonal antibody that binds soman was used 
in a competitive inhibition enzyme immunoassay with a 
quantitative determination limit of 200 ng/ml(Hunter &t al, 
1982). 
The use of chromatographic procedures for the deter-
mination of organophosphorus insecticides became popular 
during the last two decennia. Gas Liquid Chromatography 
(GLC) with specific detectors such as flame photometric 
and thermionic detectors is used frequently (Thornburg, 
1979). A mass-selective detector was used in recent re-
ports on the determination of soman in biological fluids 
(Beck 4t ai, 1981; Singh at al, 1985). High Pressure Li-
quid Chromatography ' (HPLC) was shown to be an adequate 
tool for the determination of paraoxon (De Neef e-t al , 
1981). These assays occur in the low ng/ml level (HPLC) 
or the level of 100 pg/ml (GLC). 
The final goal of the analytical procedure is the 
determination of those plasma concentrations of soman that 
can be expected to occur in experimental animals. 
According to Benschop ei al (1981a) these concentrations 
could be as low as a few pg/ml. Only the radioactive 
tracer method used by Martin (1985) allows to quantify at 
this low level. However for the assay of soman this 
method cannot be used because the assay should be able to 
distinguish, either directly or indirectly, between the 
four isomers of soman. We describe a GLC technique that 
distinguishes between the diastereoisomers with a 
detection limit in the required range. 
11.2. ELEMENTS FOR THE DESIGN OF A USEFUL METHOD. 
11.2.1. Separation of isomers. 
The four stereoisomers of soman were separated by 
Benschop e¿ al (1981b) on a coupled capillary system con-
sisting of a polyethylene glycol coated column and a chi-
rasil-val (chiral) column (fig II.1.a.). The isomers were 
assigned as indicated, based on (1) a stereoselective 
effect of enzymatic degradation in favour of a more rapid 
degradation of the P(+)-isomers, which was verified by op-
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tica! rotation measurements, and 
and C(-)P(±)-epimers of soman 
column, the stereoisomers 
Il.l.b.), while on the 
mV 
(2) the use of C(+)P(±)-
On the chirasil-val 
are only partly separated (fig 
polyethyleneglycol column (fig 
• ) P ( ± ) 
C M P H 
C H P H 
C ( - ) P ( - | 
C(* )P( - ) 
C( - )P (» | 
C U I P ( » ) 
C(- )P( - I 
(a) (b) (c) time 
Figure II—1. : GLC separation of the soman isomers on va-
rious capillary columns (Benschop c-í a-¿, 1981b). 
(a) Combined polyethylene glycol (carbowax) and chira-
sil-val . 
(b) Chirasil-val. 
(c) Polyethylene glycol (carbowax). 
II.I.e.) the diastereoisomers are separated (Verweij e¿ al 
1972). Knowledge of the assignment in fig. II.1.a. and b. 
strongly suggests that the first peak of soman on fig. 
is composed of C(-)P(+) and C(+)P(-) while the se-ll.1.с 
cond peak contains C(+)P(+) and C(-)P( 
confirmed by Benschop e¿ al (1981b) 
• ) This was 
The analytical methoa of choice for the determination 
of soman therefore is based on capillary gas 
chromatography. The other parts of the technique, V-L^. , 
sample preparation, injection system and detection remain 
to be optimized. 
11.2.2. Sample preparation. 
Before a biological sample can be worked up it may be 
necessary to stabilize the analyte, i.e. prevent it from 
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further reaction. Christen (1967) showed that in plasma of 
various species, the enzyiiiah/ic degradation of sarin is ef­
fectively stopped by и г inging ene ¡Л asma at a pH of 4. 
However, in the ligh. of recent findings by Benschop at al 
(1985) this might not be practicable at low soman con­
centrations, at least not in rat plasma, since a pH < 5 
induces a regeneration of soman by a refluorination of 
aliesterase-bound soman. Control of the stability of so­
man thus is a prerequisite for further sample preparation. 
A sample preparation procedure which is frequently 
used for the determination of pesticides, consists of an 
extraction, sometimes followed by a clean-up and/or a con­
centration of the extract, prior to the injection in a gas 
Chromatograph. Solvent extraction of samples is a fre­
quently employed technique (Ford et al, 1975). However, 
this method is unselective, giving background levels that 
may interfere with the detection of the analyte. 
The use of polystyrene based neutral resins (Amberli-
te, XAD) as solid adsorbents for the separation of organic 
compounds from biological fluids (solid phase extraction) 
has been described by Bradlow (1968). Its application in 
hemoperfusion of parathion-intoxicated dogs has been in­
vestigated (Eigenberg e.i al , 1983). The preparation of 
the resins, however, is time-consuming (Hun., and Pangaro, 
1982). 
An octadecyl modified silica was used for the extrac­
tion of organic compounds from biological samples 
(Shackleton and Whitney, 1980) and water (Saner and Gil­
bert, 1980). For the assay of soman, it therefore seems 
useful to try an analogous extraction based upon hydro­
phobic interactions of the C-18 column with the pinacolyl 
moiety of soman. Elution with benzene or ethyl acetate 
should allow an evaporation/concentration of the extract 
to about 30 yl without gnacceptable losses. 
11.2.3. Internal standard. 
Due to the complexity of the matrix and the fluctua­
ting losses that can occur during extraction and concen­
tration, large variations in the overall recovery of the 
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sample preparation are possible. These problems can be 
overcome by using an internal standard (Currie, 1976) with 
a structure similar to the soman molecule. The synthesis 
of a soman analogue with a minimum change in the ester 
group is therefore required. 
11.2.4. Sample injection. 
To bring the determination limit as low as possible, 
it is necessary to inject an as large as possible fraction 
of the extract into the Chromatograph, injection of the 
complete sample (Wilse-í al y 1986), of course, is the ab-
solute limit. 
Splitless injection with solvent effect (Grob and 
Grob, 1969) allows routine injection of five microliters 
on a capillary column (Brötell ç.t al , 1979). The tech-
nique is based on the use of a solvent with a boiling 
point that is about ^ C higher than the column temperatu-
re (Grob and Grob, 1978). The solvent, together with the 
analytes, is transferred through a hot injector into the 
capillary inlet section of the column where they condense. 
The chromatography then occurs in two steps (Grob, 1982). 
Firstly, the condensed solvent acts as a stationary phase 
where the analytes are trapped, and undergo band narrowing 
(Deans, 1972; Grob and Grob, 1978). Secondly, normal 
capillary chromatography proceeds. As far as the solvent 
itself is concerned vapours elute faster in the normal 
stationary phase than in the condensed solvent stationary 
phase. The solvent vapour thus will catch up with the 
condensed solvent plug. This gives the solvent peak a 
sharp cut-off, almost without any tailing. In order to 
apply this technique, a sufficiently high boiling solvent 
with a good trapping efficiency for soman is required. A 
minimum quantity (about fifty microliters) of this solvent 
will be added to the extract prior to the concentration 
step. 
11.2.5. Detector. 
The choice of a detector will be the result of a com-
promise between maximum selectivity and optimum detectabi-
lity. The mass spectrometer is a highly selective detec-
tor. Quantitative selective ion monitoring (QSIM) is a 
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frequently used technique for the determnation or drugs 
and "heir ¡nezabol ites in biological tissues (Garland ana 
Powell, 1981). Preliminary experiments, however, indicate 
tnat this technique does not reach the detection limiL of 
the less selective Nitrogen Phosphorus Detector (fJPD). 
This detector, first described by Karmen and Giuffrida 
(1964), is based on the increased response for certain 
eledients, like boron, phosphorus, arsenic and nitrogen 
(incorporated in an organic molecule), when alkali vapours 
are added to a flame ionization detector. Ten years later 
¡чоlb and Bischoff (1974) described a new version with an 
electrically heated Rubidium bead replacing the alkali 
sale tip. This version is more stable and show£ lebs 
noise. Moreover it can be selectively tuned for nitrogen 
and phosphorus or phosphorus alone. The detailed 
operating mechanism is still subject to of discussion 
(Kolb <Lt al, 1977; Patterson, 1978). The instru;¡iencal 
detection limit, however, is as low as 5 χ 10 g 
Phosphorus/second. This value will be used for estimation 
of the detection and determination limits of our rnetnod. 
This will be discussed in the following section. 
11.3. ESTIMATES OF DETECTION AND DETERMINATION LIMITS. 
In quantitative analysis the concentrai, i on of solute 
is determined by measurement of a signal, or J he ratio of 
two signals (when an internal standarc ι _ usea). The- sig­
nal of the solute, must be read agaiist the background 
signal (blank response or noise). For a mass selective 
detector, such as an UPD, the inst, umentai detection ІІІЛІ, 
(Lüm) is defined as the mass flow that exceeds tho noise 
level by a factor of 1.5 (Kaiser, 1965; Scot.. ^ / T ) , 
expressed in g.s '. The LDm is given by the manufacturer. 
Trrs Lüm -value, however, dees not take into account any 
se 'pie preparation and chromatograpnic partition on the 
analytical column. 
The real detectV"i ь .;,. there-fofií is . lîj.ted to the com-
piere procedure and, in this case, is '• K.e expressed in 
g "'ins of sonan per milliliter serum or ρ-asiría. 
Í4 
In the evaluation of the detection limit the quality of 
the chromatographic column has to be taken into account; 
the quality of column can be expressed in very general 
terms as the number of effective plates or by the peak 
с 
σ 
a 
с 
О) 
¿л 
inj 
VA 
time 
Figure II-2. : Statistical approach of a chromatographic 
peak (ideal case - gaussian partition). A peak at the le­
vel of the signal detection limit is supposed to elute. 
For a constant retention time, t , the higher the number 
of theoretjcal plates, the smaller w (n - 5.54 (—) ) 
w 
and the less compound (proportional to the area under· the 
gaussian curve) is needed to reach the detection limit. 
with (w) at 0.607 times the peak height (Figure II-2.). 
The area under the peak is a measure of the quantity of 
phosphorus injected and is, approximately : 
LDm . w 
This represents the value of the detection limit in grams 
of phosphorus at the detector and for a specified column. 
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If the total recovery from the sample is estimated to be 
50 per cent, then the fraction of compound injected in the 
gaschromatograph is : 
Vinj · 0 · 5 
V
el 
where V. . is the volume injected and \/ , is the volume of inj el 
(concentrated) eluate. 
The quantity of phosphorus (from soman) present in the 
sample at the level of detection limit is : 
LDm . w . V , 
el 
Vnn-i · 0 · 5 
inj 
Then, the procedure detection limit, LDp, expressed as 
quantity of soman per milliliter of sample value is : 
LDm . w . V , 
LDp = 
f
c ·
 0
·
5
 •
 Vinj ' Vsample 
where V ι is the sample volume (in ml) and f is the 
sample r с 
conversion factor, quantity of phosphorus/quantity of 
soman. 
An estimate of LDp can be calculated using LDm = 5 χ 
10 g phosphorus/s (this is the instrumental detection 
limit of the NP detector, as given by the manufacturer), w 
= 5 seconds, V , = 30 μΐ, f = 0.17 g of phosphorus/gram 
of soman, V, . = 5 μΐ and V,.,„„, = 1 ml : inj sample 
LDp = 1.8.10 g soman/ml ^ 10 pfl soman. 
The limit of quantitative detection (determination limit) 
can be estimated to be about 2 times higher (Currie, 
1968), i.e. 4 pg soman/ml (some 20 pM). 
These limits have to be checked against the practical 
background current (interfering peaks). It can reasonably 
be expected that the effective determination limit will be 
higher because the practical background current was not 
taken into account in this introductory evaluation. 
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II.4. MATERIALS AND METHODS. 
11.4.1. Glasswork. 
All glass material is rinsed with acetone and water. 
It is subsequently cleaned in hot concentrated nitric acid 
for 1 hour, rinsed with tap water, then with distilled wa-
ter and finally dried at 120oC. 
11.4.2. Reagents and solvents. 
2-Propanol, ethyl acetate and benzene (for conditio-
ning of cartridges) were of analytical grade, benzene (for 
elution of loaded cartridges) was "für die Rückstand-
analyse" and butyl acetate was of spectroscopic grade. 
Tris buffer was prepared with 50 mM of 2-amino-2-hydroxy-
methyl-1,3-propanediol and adjusted to pH 7,4 with a 10 % 
NaOH solution in water; buffer (pH 2) was prepared from 
Titrisol R (citrate-HCl ). Reverse phase cartridges were 
Sep-рак R (350 mg). 
C(±)P(±)-soman and internal standards were prepared accor­
ding to the synthesis of sarin by G. Schrader starting 
from dimethyl methylphosphonate as described by Saunders 
(1957). DFP was synthetized according to Saunders and 
Stacey (1948). 1\\- and 3 2 P-NMR spectra showed data con­
sistent with the structure of the compounds and a purity 
exceeding 95 %. Solutions of soman and internal standard 
in 2-propanol have a sufficient stability to be used 
during several months. 
C(+)P(±)-soman was obtained from the Prins Maurits Labora­
tory - TNO (see IV.2.1.). 
11.4.3. Samples. 
Pooled sera or plasma from humans or dogs is used, as 
described in chapter III. 
11.4.4. Apparatus. 
Two capillary gas chromatographs were used : a Perkin 
Elmer Sigma 2 and a Perkin Elmer 8320, both equipped with 
a splitless injection system and a nitrogen phosphorus de­
tector, functioning in the NP-mode. The columns are 25 mm 
χ 0.22 mm i.d. fused silica capillary, wall coated with a 
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crosslinked polyethylene glycol phase (CP Wax 57 CB -
Chrompack B.V.). Injector and detector temperature are 
170° and 200oC, respectively. The column temperature is 
80oC during analysis time (10 to 20 min), followed by a 
rapid (40oC/min) heating to 180oC where it is kept for 3 
minutes. This temperature programming is used to eluate 
the less volatile components of the extract. The carrier 
gas is nitrogen with a column head pressure of 180 kPa (26 
psi). Air and hydrogen pressure are 165 kPa (24 psi) and 
62 kPa (9 psi), respectively. The septum and injector 
vent remain closed until 36 seconds after the injection. 
The vent flow after opening is 2 ml/mi η for both septum 
and injector. The rubidium bead is electrically heated to 
obtain a background current of 50 % of full scale (1 mV) 
at an attenuation of 32. For the Perkin Elmer 8320 the 
level of the background current is controlled by a 
microprocessor. The volume injected is 5 μΐ. 
In the course of several hundreds of injections the 
column resolution decreases. This can be due to a poiso­
ning of the liquid phase by less volatile components, or 
also to unstable components that dissociate on the column. 
Flushing the column with solvents is a way to overcome 
this problem if the phase is crosslinked (Blomberg eé al , 
1981). The detector side of the column is coupled to a 
HPLC-pump and 10 ml of methanol/water (80/20), 10 ml of 
clichloromethane. Subsequently 10 ml of pure methanol are 
pumped through the column. 
11.4.5. Extraction and clean-up. 
Figure II-3 shows the general extraction and clean-up 
schedule that is used in the assay of soman from aqueous 
solutions. 
Sep-рак C18 cartridges are conditioned by pre-elution 
with 4 ml of ethyl acetate, 2 ml of pH 2 buffer and 4 ml 
of benzene. Samples of 1 ml are of aqueous solutions ad­
justed to pH 4 with pH 2 buffer to stop the degradation 
processes of soman (Christen, 1967; see also figure 
II.7.). Immediately thereafter internal standard is added 
and the sample is pressed through the cartridge by means 
of a glass syringe. The cartridge is centrifuged to remo­
ve excess of water. 
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1 ml of serum, plasma or buffer 
adjust to pH 4 
\ 
add internal standard 
\ 
extract with C-18-cartridge 
[Soman] < 20 nM 
I 
Elute with 4 ml of 
benzene 
Addition of 50 μ 1 
butyl acetate 
* 
concentrate under N, 
to 30 μ 1 
f Soman] > 20 nM 
Elute with 2 ml of 
benzene/butyl acetate 
or ethyl acetate/Butyl 
acetate 
inject 5 μΐ in GLC 
Figure II-3. : Assay of soman in aqueous solutions 
Extraction and clean-up. 
ifW4. '' 
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For low soman concentrations (< 20 nM), elution of the 
cartridge is done with 5 ml of benzene. The eluate is 
centrifuged (4000 rpm, 5 min) to separate residual water, 
and the benzene fraction is transferred to a vial with a 
conical tip and a marking at 30 μΐ. Butyl acetate (50 μΐ) 
is added and the whole is concentrated under nitrogen flow 
to a volume of about 30 μΐ (the concentration step takes 
about 1 h). 
For higher soman concentrations (> 20 nM) 
ried out with a mixture of benzene/butyl 
v/v) or ethyl acetate/butyl acetate (50 %, 
centration step is omitted in this case. 
tridges are re-used up to eight times. 
elution is car-
acetate (50 %, 
v/v). The con-
Extraction car-
Figure II-4. Gaschromatogram of a 
-1 
mixture containing soman (80 ng.ml ) 
and internal standards IV (70 ng.ml 
,-1 
-1 
and V (120 ng.ml )in butylacetate. 
The diastereoisomers of each compound 
are resolved. 
Identification : 1, 2, compound IV 
(1,2 dimethylpropyl methylphosphono-
fluoridate); 3, 4, soman (1,2,2-tri-
methylpropyl methylphosphonofluorida-
te); 5, 6, compound V (1,3,3-trime-
thylbutyl methylphosphonofluoridate). 
G.C. conditions : fused silica capil­
lary column (25 m χ 25 mm i.d.) coated 
with CP Wax 57 CB. Column temperatu­
re : 800C; injector : 1700C; detector: 
2000C; carrier gas N . Inlet pressure: 
12 MIN 
180 kPa; attn. 32; five 
are injected splitless. 
microliters 
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11.4.6. Qualitative analysis. 
Peak identification is based upon calculated reten­
tion times and relative retention times. The calculated 
retention time { t c ) is obtained by subtracting the re-
π 
tention time of the complete solvent plug Ц ) from the 
absolute retention time (t ) (figure II-4.). Relative 
retention times are determined from the calculated reten­
tion times by taking tne first peak of the internal stan­
dard as a reference (-c.e. relative retention time = 1.00). 
The isoiner(s) of soman corresponding with a peak were as­
signed according to the work of Christen and Benschop, as 
explained in chapter I, and summarized in Table II-l. 
TABLE I I - l : Soman peak i d e n t i f i c a t i o n f igure ll-A for 
d i f f e r e n t types of soman i n j e c t e d . 
Soman type Peak 3 Peak 4 
C(±)P(±) b C(
 + )P(-) С Ы Р Ы 
СЫРЫ СЫРЫ 
СЫРЫ
 с
 С Ы Р Ы С Ы Р Ы 
С(-)Р(±) d СЫРЫ СЫРЫ 
based upon the GLC analysis by Benschop ел' a¿ (1981b). 
4 isomers present. 
C(+)P(±)-soman, synthesized from C(+)-pinacolyl alcohol, 
C(-)P(±)-soman, synthesized from C(-)-pinacolyl alcohol, 
31 
11.4.7. Quantitative analysis. 
For the internal standard a choice has to be made 
between two candidates, selected on the basis of their 
structure which is similar to that of soman (Table 11-2). 
Under normal procedure the internal standard is added be-
fore extraction and clean-up. The ratio of peak heights, 
sonian/internal standard, is calculated. 
TABLE II-2 : Sen ¡.-developed formula and nomenclature of 
soman and internal standards. 
Structure Code Name 
О H H 
II I I 
F - P - 0 - C - C - C H „ 
ι ι ι
 J 
CH„ CH3 CH3 
IV 1,2-dimethylpropyl 
methylphosphono-
fluoridate 
3 ο H сн 
и ι ι 
F - P - O - C - C - C H . 
I I I " 
CH, с н
з
 с н
з 
Soman 1,2,2-trimethylpro-
pylmethylphosphono-
fluoridate 
0 
II 
Ρ - 0 -
с н
з 
Η Η 
ι I 
- с - с -
сн 3 н 
« 3 
- с - сн. 
с н
з 
1,3,3-trimethylbu-
tyl methylphospho-
nofluoridate 
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i 1.5. RESULTS AND DISCUSSION. 
Figure 11-4 shows a representative chromatogram of 
soman and internal standards in butyl acetate. The latter 
is used as a trapping solvent for the splitless injection 
technique. The repeatability of the injection is estima­
ted from the calculation of the ratio of peak heights ana-
lyLe/internal standard for a number of subsequent injec­
tions. C(±)P(±)-soman was used and the results for total 
soman (= sum of the two peaks) are given in Tables II-3 
and Ii-4. It is seen that an increase in injector tempe-
a 
TABLE II-3 : Repeatability of chromatographic response 
with internal standard (IV) 
injector Apparatus Amount of Relative Range η 
tempera- C^JPft) standard 
ture injected deviation 
(0C) 
170 
150 
170 
170 
]70 
170 
170 
Sigma 
Sigma 
Sigma 
Sigma 
8320 
8320 
в^го 
2 
2 
? 
2 
ipg) 
400 
60 
60 
30 
400 
60 
30 
(30 
1 .4 
5.6 
3 
5 
1.7 
0.7 
І.7 
(%) 
4 
19 
8 
16 
4 
2 
5 
9 
10 
10 
11 
9 
9 
8 
The ratios of the sum of peak heights of soman and the 
sum of peak heights of internal standard (IV) are 
calculated for a number of subsequent injections under 
the chromatographic conditions mentioned in figure 11-4. 
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rature fren 15ü0C to 170оС results in an improvement in 
relative standard deviación. The control of the 
background current by a microprocessor results for the PE 
S320 instrument in a decrease of the relative standard 
deviation as compared with the manually Sigma 2. There is 
no difference in results between both chromatographs used 
or between both internal standards. 
TABLE II-4 : Repeatability of enromatographic response 
wiLh internal standard (VJ. 
Appara-
b 
tus 
Sigma 2 
Sigma 2 
8320 
832C 
Amount, of 
ι nject 
fpg) 
400 
30 
60 
30 
CU 
ed 
;Pi±) Relative 
s randard 
deviation 
(%) 
1.4 
3.3 
2 
1.3 
Range 
(%) 
3 
12 
6 
4 
Number of 
determina­
tions 
9 
11 
9 
8 
The ratios of the sum of peak heights of soinan and the 
sum of pe^k heights of internal standard (V) are 
calculated for a number of subsequent injections under 
the chromatographic conditions mentioned in figure II-4. 
Injector temperature 170°C. 
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According to the literature (Onuska e¿ al, 1983; 
McMahon, 1985) one can expect that on-column injection 
will give a better repeatability than splitless injection. 
However, with splitless injection solutes are transferred 
to the column indirectly, i.e.. through an evaporation 
step. Less volatile components of the plasma or serum 
extract are retained in the glass liner and thereby pre-
vented from contaminating the column. After some 50 in-
jections of 5 μΐ the glass liner is cleaned. The split­
less injection technique, however, has two main disadvan­
tages. Firstly, the absolute retention times vary with 
the amount and secondly, the composition of the solvent 
injected (Grob and Grob, 1978), and a discrimination in 
transfer efficiency from injector to column exists for 
solutes with different volatilities (Onuska <L-Ì al, 1983). 
The latter disadvantage can be corrected by using an 
internal standard with a structure as similar as possible 
to soman (Table II-2). To allow peak identification with 
varying absolute retention times, calculated retention 
times are used in combination with relative retention 
times (De Bisschop and Michiels, 1984). Table II-5 shows 
the variation in relative retention times of the two soman 
peaks : for a new column, or immediately after purging, 
the relative retention times are fairly constant with an 
r.s.d. within the series better than 1 %. Calculated 
retention times, though, have a higher standard deviation. 
With an increasing number of injections the column becomes 
more contaminated. Relative retention times tend to 
increase and also show a greater variability within the 
series. For identification purposes both calculated 
retention times and relative retention times are used with 
a window of ± 2 x r.s.d. The reference values are 
determined from a series of calibration samples. 
For the assay of low concentrations of soman, concentra-
tion of the eluate is necessary. Benzene is used as an 
eluate because of its low background. It can be used up 
to after a hundred fold concentration. Table 11-6 shows 
the repeatability of the concentration step for various 
amounts of soman. The amount of soman seems to have no 
influence on the results. However, the relative standard 
deviation (r.s.d.) with internal standard IV appears to be 
slightly better than with internal standard V. Estimates 
of the losses that occur during the concentration step are 
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co a a 
TABLE II—5 : CalculaLed retention times and relative retention times 
soman peaks on a Carbowax capillary column. 
for noth 
Number 
of de-
termi-
na-
tions 
First eluting soman peak 
t(min) 
Relative re-
tention time 
Second eluting soman peak 
t (min) 
Relative re-
tention time 
Remarks 
18 3.52+0.07 1.24510.007 
12 4.39±0.16 1.458+0.018 
13 3.79+0.10 1.251±0.006 
3.81+0.07 1.345±0.012 
4.7510.17 1.579+0.022 
4.19±0.14 1.354±0.006 
new column 
3 
after -v 10 
injections 
immediately 
after 
flushing 
± standard deviation. 
Each peak represents an enantiomeric pair. Chromatography as in figure II-4, 
TABLE ІІ-б : Influence of the evaporation/concentration 
step on the repeatability of the response 
Amount C(±)P(±)added 
to 5 ml of benzene 
10 
500 
ng 
Pg 
с 
Relative 
Soman / 
3.5 
4.5 
s 
IV 
tandard deviation 
Soman 
6.9 
6.7 
. on 
/ V 
5 ml of benzene is spiked with various amounts of 
C(± )P(± )-soman, compound IV and compound V; 50 μ 1 of 
butyl acetate is added and the whole is concentrated to 
50 μΐ in about 1 hr. 
The ratios of the sum of peak heights of soman and the 
sum of peak heights of IV, respectively V are determined 
for eight subsequent injections and the relative 
standard deviation is calculated (n = Ъ). 
The amounts of C(±)P(±)-soman, IV and V are about equal. 
concentration step are given in table II-7. The values 
are in the same order of magnitude for all three compounds 
(soman, IV and V). 
When higher soman concentrations (> 20 nM) are deter­
mined, instrument sensitivity is sufficient to drop the 
concentration step and a mixture of benzene/butyl acetate 
or ethyl acetate/butyl acetate (50/50 v/v) can be used, 
without evaporation. 
The volume of eluent (benzene or benzene/butyl ace­
tate) that is needed for a nearly complete elution of the 
adsorbed compounds has to be minimized to keep the time of 
the concentration step restricted. The minimum amount of 
solvent, necessary for quantitative elution is estimated 
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TABLE II- 7 : Loss of solute during solvent concentra­
tion. 
% Loss 
Soman 
16 ± 8 b 
IV 
13 ± 7 b 
V 
14 ± 7 b 
Values are obtained as follows : (1) phosphonofluorida-
tes (soman, IV and V) and DFP (each about 1 ng) are ad­
ded to 50 μΐ of butyl acetate and the ratio's of peak 
heights of the phosphonofluoridates and DFP are determi­
ned. (2) The same amounts of phosphonofluoridates are 
added to 5 ml of benzene containing 50 μ 1 of butyl ace­
tate, the solution is concentrated to 50 μΐ (in about 
one hour), DFP is added and the ratio's of peak heights 
are determined. 
With the ratio's obtained under (1) as reference values 
(100%) the percentage phosphonofluoridates remaining 
after concentration can be calculated and hence the per­
centage of loss. 
± standard deviation (n = 6). 
from its elution pattern. A loaded cartridge is eluted 
and the eluate is collected in 1 ml fractions. Each frac­
tion is assayed for soman and the result, expressed as 
percentage of total eluted soman, is shown histographical-
ly in figures II-5 and 11-6. It can be inferred that 3 ml 
of benzene/butyl acetate is sufficient for quantitative 
elution, whereas for benzene 5 ml is needed. 
Extraction efficiencies were determined for soman and 
compounds IV and V (candidate internal standards) from 
plasma and tris-buffer and for different concentrations 
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χ 
I 
5 3 . 
1 2 3 4 5 
П ^ 
τ 
1 2 3 4 5 1 2 3 4 5 
Τ 
1 ML FRACTIONS 
OF ELUENT 
Figure II-5. : Elution patterns for C18 cartridges loaded 
with 10 ng soman and eluted consecutively with 1 ml por­
tions of benzene. The amount of soman eluted per ml of 
benzene is assayed and shown as a percentage of the total 
eluted amount of soman. 
1M 
_ & . ÉEL. 
I ML FRACTIONS 
OF ELUENT 
Figure II-6. : Elution pattern for a C18 cartridge loaded 
with 10 ng soman and eluted consecutively with 1 ml por-
tions of a mixture of benzene/ethyl acetate (50/50, v/v). 
The amount of soman eluted per ml of eluate is assayed and 
shown as a percentage of the total eluted amount of soman. 
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-p» TABLE ΙΙ-8 : Extraction efficiencies from plasma and tris buffer at various concen-
О 
tration levels of soman, compound IV and compound V. 
10 ng/ml 500 pg/ml 100 pg/ml 
(50 nM) (2.5 nM) (0.5 nM) 
Plasma Tris Plasma Tris Plasma 
Compound IV 73 ± 12 89 ± 16 C 84 ± 7 77 ± 10 86 ± 11 
C(±)Pi ±J-somand 82 ± 9 79 ± 5 82+14 82+10 79 ± 10 
Compouna V Ь 64 ι 16 73 ± 12 76 ± 3 68 + 7 e 86 ± 5 
+ standard deviation. Tris buffer or plasma is spiked with the analyte, pressed 
through a cartridge, eluter1, standard is added and the ratio of peak heights of 
analyte and standard determined (sum of peaks); this ratio is compared against the 
ratio of analyte and standard, when both are added to the eluate (= 100 % value). 
Determined with C(+)P(±)-soman as internal standard. 
C
 η = 4. 
Determined with compouna U as internal standard. 
e
 η = 3. 
levels. The analyte was extracted and the standard was 
added to the eluate prior to concentration (when 
appropriate) and injection. The values of the peak height 
ratios are compared with the values obtained when the same 
amounts of analyte and standard are added directly to the 
same volume of eluate. The results are given in table 
II-8. The variability of the extraction efficiency of so­
man is large enough to justify the use of an internal 
standard. The repeatability of the concentration step 
(table II-6) and of the extraction efficiency (table II-8) 
is slightly less favourable for compound V than for com­
pound IV, but both show a comparable chromatographic re­
peatability (tables II-3 and II-4). Compound IV (1,2 di-
methylpropyl methylphosphonofluoridate) will be the inter­
nal standard of choice also because this compound elutes 
before soman, which allows a shorter chromatographic time. 
Re-use, to eight times, of the C-18 cartridges does 
not seem to have a notable influence on the mean values of 
the peak height ratio of soman and internal standard in 
the high molecular range (table II-9). 
The stability of soman and compounds IV and V in 
not-preincubated serum, adjusted at pH 4 with pH 2 buffer 
is shown in figure 11-7. Soman and compound IV are about 
equally stable but compound V shows an important degrada­
tion during the first minutes. This is probably due to a 
more rapid phosphonyiation at serum proteins. These 
findings support the choice of compound IV (1,2-di-
methylpropyl methylphosphonofluoridate) as internal 
standard._ In human serum, preincubated with soman, up to 
2.5 μΜ F ions are present, mainly due to hydrolysis and 
irreversible protein binding of the soman used for 
preincubation. It therefore has to be checked whether at 
pH 4.0 a regeneration of soman occurs as described in rat 
plasma (De Jong and Van Dijk, 1984; Benschop e¿ al, 1985). 
Human serum, preincubated with 1 μΜ soman, was adjusted at 
pH 4.0 with a 10 % HCl solution and analyzed for soman at 
various time intervals. Even after 20 min at pH 4.0 no 
soman could be detected at a threshold level of 500 pM. 
Analogous experiments were performed in human serum that 
was preincubated with compound IV. No regeneration of 
compound IV was detectable at the 500 pM level. In 
conclusion, adjusting the pH at 4.0 sufficiently 
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О 20 40 60
 M I N 
Figure II-7. : Stability (at 250C) of soman and compounds 
IV and V in not-preincubated human serum adjusted at pH 
4.0 with pH 2 buffer. 
Concentrations in serum, C(±)P(±)-soman [Ol : 4 ng/ml; 
compound IV [D] : 3 ng/ml; compound V [Δ] : 6 ng/ml. 
Soman, IV and V are simultaneously added to serum. DFP (2 
ng/ml) is added as internal standard. 
stabilizes both soman and compound IV (internal standard) 
in preincubated human serum as well as in not preincubated 
human serum. 
The repeatability of the analytical technique is gi­
ven in table 11-10. This repeatability can be used as a 
criterion for the estimation of the determination limit, 
to be defined as the concentration at which the accuracy 
of the determination is just sufficient to allow 
quantitative determination. The criterion that is normal­
ly accepted is a relative standard deviatioi (determina­
ción characteristic) that is < 10 % (Liteanu and Rica, 
1980). According to this criterion and the results of ta-
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TABLE II-9 : Influence of the re-use of C18 extraction 
cartridges on the peak height ratio of 
C( + )P(-)- and C( + )P( + )-sonian vesciui internal 
s tandard (IV). 
Quality of Sep-рак C(+)P(-) C(+)P(+) 
cartridge 
New 1.42 1.09 
8th time used 1.36 1.04 
C( + )P(±)-soman (101.3 ng) and IV (38 ng) are added to 
plasma, that was previously brought at pH 4.0 rfith pH 2 
buffer; extraction and elution are done as described 
under Materials and Methods and the peak height ratio is 
calculated from the chromatogram. 
ble 11-10, the determination limit for total soman (= sum­
mation of the four isomers) would be circa 40 pg/ml for a 
sample size of 1 ml of human serum. A representative 
chromatogram at this level is shown in figure 11-11. This 
limit may still be lower if the sample size can be 
increased provided that the biological contamination does 
not increase proportionally. 
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TABLE 11-10 : Relative standard deviation of repe^-tive 
determinations of soman in human plasma. 
Soman 200 152 76 38 19 
concentration 
(pg/ml) 
relative 8.5 8.7 9.6 10.1 12.5 
standard 
deviation 
For each concentration five 1 ml samples are prepared 
with the indicated amount of soman and 78 pg ir.ternaJ 
standard ÍV. 
C(± )P(±)-soman; toLal soman is deterrr.ined ns thf- .-.'j- of 
the two peaks. 
Another criterion for quantitative determination sta-
tes that the absolute error + 2 x r.s.d. should be under 
25%. For different concentrations, assays of sorndn "¡n 
plasma are made using a calibration curve. So.;,an 
concentrations for the assays on the one hand and those 
for the calibration curve on the other hand are made f rom 
different primary soman standards (^  10 ng/ICú ¡ni 
2-propanol). The results are summarized in table 11-11. 
All determinations are wirnin the accepted limit of 25*. 
According to this criterion the -ieterrinetion limit is at 
least better than 140 pg/inl. 
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TABLE 11-11 : Quant L tn 1.1 ve d e t e r m i n a t i o n l i m i t of soman i n human serum. 
son.an a i d e J sor.an r d e t e r m i n e d C i i t e r i o n 
soman ,, ,-soman, ,_ 
added de terminad 
mtan value i. rsd 
(ng/ml) (ng/ігіі) (%1 soman ,, , 
added 
χ 100 + 2.rsd 
ιε.? 
7.9 
15.9 
21.5 
23.4 
2?.6 
C(±)P(±)-soman is used; total soman (sum of two peak.i) is deierniined, using a cali­
bration curve. 
¿^  Criterion value shoiild be < 2^ for acceptable quantitative determination 
7 .11 
2 . 7 3 
0 .711 
0 . 2 3 4 
0 .237 
0 .142 
6 . 6 5 
2 . 2 5 
0.731 
0 .25S 
0 . 2 5 1 
0 . 1 2 5 
5 
4 
4 
3 
3 
3 
5 . 7 
2 . 0 
6 . 6 
5 . 7 
8 . 7 
4 . 5 
mV 
J £ 
П 
С 
MIN 
Figure II-8. : Gas chromatogram 
from the assay of a one ml serum 
sample containing 38 pg soman and 
76 pg internal standard (IV). GC-
conditions as in figure II-4. 
Identification : 1, 2, 1,2 dime-
thylpropyl methylphosphonofluori-
date (internal standard, IV); 3 
and 4, 1,2,2-trimethylpropyl me-
thylphosphonofluoridate. 
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The assay of the four, chromatographically resolved, 
isomers of soman and its application for the study of the 
toxicokinetics of soman in the rat has been described 
recently (Benschop el ai , 1985). Our method does not 
allow the simultaneous determinaiion of the four soman 
isomers because a stabilized (cross-linked) optically 
active coating, which can separate the four isomers, is 
not yet available. However, if C(+)- or C(-)-epimers are 
used resolution is possible on an achiral capillary 
coating (Table II-l). Concerning -ui v^vo toxicokinetic 
studies, it should be stressed that the use of C( + )P(t) 
and C(-)P(±) cannot be considered as a substitute for the 
nerve agent soman, which is present as C(±)P(±). In the 
latter case, four isomers will compete for reactions in­
volving intoxicaiion and biodégradation. The use of 
C( + )P(±) and C(-)P("!:) only allows to draw conclusions 
comparing two isomers at a time, limited to biochemical 
reactions in v< • c-. 
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The interpretation of the results obtained, using the 
forementioned epimers will be valid only under the 
presumption that no racemisation occurs at the α-carbon of 
the pinacolyl moiety. There are at present no indications 
that such a racemisation occurs. 
The four isomers of C(±)P(±)-soman can sometimes be quan­
tified indirectly when some biochemical reactions, stereo­
selective at phosphorus, are studied. This will be 
discussed in the following chapter. 
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CHAPTER III. 
DEGRADATION OF SOMAN IN HUMAN SERUM. 
III.l. INTRODUCTION. 
To gain insight in the degradation processes of soman 
during work-up procedures, we conducted an -иг vj-t/ю study 
on the fate of soman in human serum. Preferably these 
degradation processes should be blocked at the time of 
sampling. 
A literature study on the biodégradation of organo-
phosphorus nerve agents (chapter I) revealed that the de-
gradation of soman in serum will consist of mainly three 
processes : (1) irreversible binding to proteins 
(Fleisher e.i ai , 1963), (2) enzymatic hydrolysis (Cohen 
and Warringa, 1957) and (3) non-enzymatic (spontaneous) 
hydrolysis. It was also deduced that the optical isomers 
of organophosphorus nerve agents can be expected to behave 
in a dissimilar fashion towards enzymatic reactions and 
protein binding. In contrast to enzymatic hydrolysis, 
spontaneous hydrolysis of enantiomers is not 
stereoselective. However, differences between epimers are 
possible. 
In this chapter the general aspects of these proces-
ses will be described using C(±)P(±)-soman. The assay of 
soman in serum, as outlined in the previous chapter and 
based on normal bore achiral capillary chromatography with 
nitrogen-phosphorus detection, was used. The chromato-
graphic method provides a complete resolution of the 
diastereoisomeric pairs. Where enzymatic hydrolysis is 
involved, further resolution of the antipodes is obtained 
from the biphasic behaviour of the degradation curves. 
Some of the kinetic experiments were carried out at an 
initial soman concentration of 50 nM, which is in the 
range of the expected -υι vivo concentrations (Benschop e.i 
al, 1981a). 
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111.2. MATERIALS AND METHODS. 
111.2.1. Materials. 
Pinacolyl dimethylphosphinate was obtained from PML-
TNO laboratories Rijswijk - The Netherlands. Paraoxon 
(p-nitrophenyl diethyl phosphate) was procured from 
Ri edel-De Haen and had a purity > 94 % (GLC/MS). All 
other chemicals used were as described in the previous 
chapter. 
Venous blood, taken from healthy volunteers was allo­
wed to clot at a temperature of 370C. Subsequently it was 
centrifuged and the collected supernatant was kept at 4 0C. 
Until over a period of maximum three days enough blood was 
collected to constitute a quantity of 300 ml serum. After 
pooling the serum was divided into fractions of 10 to 15 
ml and then stored at -180C. The stored fractions were 
used within 8 weeks after collection. The 300 ml volume 
of pooled serum was obtained from about 100 blood donors. 
Serum ultrafiltrate was prepared from separately 
Τ M 
produced freshly collected serum using a Mini tan 
crossflow ultrafiltration system (Millipore) with a mole­
cular weight cut off of 30,000 or 100,000 NMWL (Normal 
Molecular Weight Limit). A volume of 300 ml was processed 
in one operation and 10 ml portions were stored at - 130C. 
111.2.2. Adjustment of pH. 
The pooled serum had a pH of 8.7 to 8.8. For some 
experiments the pH was left unchanged. For other experi­
ments the pH was readjusted to the physiological value of 
7.4 by slowly bubbling gaseous CO through the serum. 
For experiments at a pri lower than 7.4 adjustment was done 
with a citrate-HCl buffer (pH 2); 1.2 ml of this solution 
was necessary to bring the pH of 1 ml of serum at pH 4.0. 
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IП.2.3. Degradation experiments. 
Samples of 1 ml serum were thermostated at 250C, At 
time t=0, soman, from a 0.5% solution in 2-propanol, was 
added to the serum. At time t the degradation was stopped 
by adding an amount of a pH 2 buffer solution to adjust 
the pH to 4.0 (Christen, 1967; see also figure II.7.). 
The samples were assayed for soman and the values were 
transformed into a "% remaining soman" using the following 
equation : 
(assayh 
% remaining soman = • ^ „,. . χ 100 III-l 
3
 (assay). _ g 
For the assay at t = 0, buffer was added to the serum 
prior to the addition of soman. 
III.2.4. Assay. 
The assay procedure was as described in detail in the 
previous chapter. The chromatogram obtained is given in 
fig III-l. Both the internal standard and soman have two 
chiral centres and therefore consist each of 4 
stereoisomers. The chromatography allows the resolution 
of the diastereoisomers. Since we used identical achiral 
GLC conditions as Benschop &i ai (1984a), we assume that 
the first peak of soman contains the C(+)P(-) and C(-)P(+) 
isomers whereas the second peak represents the C(+)P(+) 
and C(-)P(-) isomers. Quantitation was done by cal­
culating the ratio of peak heights of soman and internal 
standard. Either total soman (sum of the two peaks) was 
quantified or the enantiomeric pairs were quantified se­
parately. 
For the calculation of the residual amount of soman 
ел-іиі time, equation III-l can be used only if the ratio 
of peak heights of soman and internal standard is a linear 
function of the concentration, with a negligible 
intercept. Calibration graphs were determined at regular 
time intervals by adding succesively 1 ml pH 2 buffer, 
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Figure III-l. : Test chromatogram of a 
mixture of 1,2,2-trimethylpropyl me-
thylphosphonofluoridate (soman) and 
1,2-dimethylpropyl methylphosphonoflu-
oridate (internai standard) in butyl 
acetate (0.1 μΜ). The diastereoiso-
mers of the compounds are separated. 
Identification : 1,2-dimethylpropyl 
methylphosphonofluondate, 1 and 2, 
1,2,2 trimethylpropylmethyIphosphono-
fluoridate, 3, [C(+)P(-) and C(-)P(+)] 
and 4 [C(+)P(+) and C(-)P(-) ]. Five 
microliters were injected splitless. 
Attenuation 32. A normal bore achiral 
capillary column was used; other chro­
matographic conditions are as 
described in chapter II. 
8 12 
MIN 
various amounts of soman and a constant amount of internal 
standard to 1 ml serum samples. The ratio of peak heights 
of soman and internal standard were plotted as a function 
of the concentration of soman in serum. The correlation 
coefficient of the graphs was better than 0.99 and the 
intercept was sufficiently close ю zero, -L.e.. the 
absolute values of the intercepts remained smaller than 3% 
of the реак height ratio obtained for a soman 
concentration of 55 nil ifigure 111-2), which, we 
considered, allowed us to use equation III-l. 
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ratio of peak height· : »oman/ internal atandard 
Soman ( n g / m l ) 
Figure III-2. : Peak height ratio of soman елш* internal 
standard (1,2 dimethylpropyl methylphosphonofluoridate) 
after extraction of 1 ml of human serum spiked with vari­
ous amounts of C(±)P(±)-soman. For this calibration line 
the intercept of 0.21 is slightly less than 3% of the peak 
height ratio of 7.02, value for a soman concentration of 
10 ng/ml (55 nM). 
111.2.5. Preincubation. 
Preincubation was performed by spiking serum with an 
organophosphate (soman, paraoxon or pinacolyl dimethyl-
phosphinate) from a concentrated solution in 2-propanol to 
obtain a concentration in serum ranging between 50 nM and 
5 μΜ. The spiked serum was kept for 17 h in a waterbath 
at a thermostated temperature of 25 (± 0.5)oC. In the 
case of soman degradation, resulting concentrations had 
dropped to below the 550 pM detection level. 
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After preincubation with paraoxon or pinacolyl di-
methylphosphinate, residual concentrations were not 
checked since these compounds do not interfere with the 
determination of soman. Where appropriate, pH was 
readjusted to 7.4, and degradation experiments were then 
started by adding soman to the preincubated serum. 
111.2.6. Calculation of rate constants. 
First-order rate constants were determined from the 
plot of the logarithm of the percentage remaining soman 
VMIU* time, using linear least squares curve fitting. 
Biphasic hydrolysis curves, due to the different 
hydrolysis rates of epimers, were resolved by the 
graphical method of residuals, used extensively in 
pharmacokinetics (Gibaldi and Perrier, 1975). 
111.3. RESULTS. 
111.3.1. Degradation in human serum without preincubation. 
Figure III-3 shows the disappearance of Cit)" ±)-so-
an (50 nM) in human serum at a pH of 8.7 as a function of 
time. More than 95 % of the soman is degraded within five 
minutes. After ten minutes soman could no longer be de-
tected. Degradation of the first and second eluting was 
claerly dissimilar, indicating at least a different 
behaviour of the epimers. The influence of the pH on the 
degradation of C(±)P(±)-soman (50 nM) is shown on figure 
III-4. With decreasing the degradation process slows 
down. It can be seen that at a pH of 4.0 no degradation 
over a one hour period, has become negligible. 
111.3.2. Influence of preincubation on the degradation of 
soman in serum. 
III.3.2.1. Preincubation with C(±)P(±)-soman. 
To study the possibility whether part of the soman 
irreversibly binds to serum proteins, human serum was pre-
incubated with increasing concentrations of soman, under 
the hypothesis that the binding capacity might become sa-
turated and that the binding sites would no longer be 
available for soman added afterwards. The results at pH 
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8.8 show that the degradation rates decrease with 
increasing preincubation concentration, until by a further 
increase of the preincubation concentration has no further 
ζ 
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о 
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а 
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« 
S 
ш 
100 
MIN 
Figure ІІІ-З. : Degradation of soman (50 nM) in human se­
rum at 250C and pH ranging between 8.7 and 8.8. Plotted 
is the percentage remaining soman еліиі time. A : Total 
soman (by summation of the two peaks). Δ : First eluting 
peak containg C(-)P(+)- and C(+)P(-)-isomers. A : Second 
eluting peak containing C(+)P(+)- and C(-)P(-)-isomers. 
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Figure III-4. : Influence of pH on the dégradation of 
C(Î)P(±)-soman (50 nM; in human serum at 250C. Percent 
total remaining soman ел-іиі time. 
pH values : 
D, 8.8; •, 7.4; O, 6.0; ·, 5.4; Δ, 4.7; A, 4.0. 
effect. A biphasic curve is tnen obtained (figure III-5). 
The preincubation concentration that is sufficient to ob­
tain these reproducible degradauon curves is estimated 
from a statistical evaluation based on ;he repetitive de­
termination of the percent remaining soman after ten minu­
tes (table III-l):the value at a preincubation with 0.5μΜ 
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differs significantly from the value at a preincubation 
with 2.5 μΜ (one sided test of the mean, with a confidence 
level of 95 %). Preincubation with 5 μΜ gives a value 
that does not differ significantly from the value at 2.5 
μΜ preincubation. It is therefore concluded that preincu­
bation with 2.5 μΜ will lead to an occupation of nearly 
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Figure III-5. : Degradation of C(±)P(±)-soman (50 nM) in 
human serum at 250C and pH 8.7 - 8.8. Influence of prein­
cubation with C(±)P(±)-soman. Serum is preincubated at 
250C during 17 hr with various initial concentrations of 
soman. Percent of total remaining soman елш* time. 
Preincubation concentration C(±)P(±)-soman,μΜ ) : O, no 
preincubation;·, 0.05; D, 0.25; •, 0.5; A, 2.5. 
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TABLE III-l : Influence of preincubation with C(±)P(±)-
soman on the degradation of C(±)P(±)-so-
man in human serum at 250C and pH 8.8. 
Preincuba­
tion con­
centration 
(μΜ) 
0.5 
2.5 
5 
Remaining soman 
after 10 min 
(%) 
33.5 
37.2 
37.4 
Relative Stan­
dard deviation 
(X) 
Number of 
determi­
nations 
6.3 
9.8 
3.8 
4 
13 
5 
Preincubation during 17 h at 250C. 
Initial soman concentration 50 nM. 
TABLE III-2 : Influence of preincubation with C(±)P(±)-
soman on the degradation of C(±)P(±)-so-
man in human serum at 250C and pH 7.4. 
Preincuba­
tion con­
centration 
(μΜ) 
0.05 
0.26 
0.52 
2.6 
Remaining soman 
after 10 min 
(%) 
6.8 
25.9 
44.6 
44.5 
Relative stan­
dard deviation 
{%) 
Number of 
determin-
nations 
23 
12 
5 
1 
4 
4 
4 
4 
. Preincubation during 17 h at 250C. 
Initial soman concentration 50 nM. 
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all adsorption sites. Table III-2 shows the influence of 
preincubation at a serum-pH of 7.4. Here, preincubation 
with 0.5 μΜ is sufficient to occupy all sites. However, 
due to possible pH changes (due to loss of C02) during 
preincubation, the soman concentration, currently used for 
preincubation at pH 7.4, is 1 μΜ. 
III.3.2.2. Preincubation 
compounds. 
with other organophosphorus 
The degradation of soman was carried out in serum 
that was preincubated overnight with 1 μΜ pinacolyl di-
methylphosphinate or with 2 μΜ paraoxon. It can be seen 
in figure III-6 that the first mentioned compound has no 
influence on the time course of the degradation of soman. 
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Figure ΙΙΙ-6 : Degradation of C(±)P(±)-soman (500 nM) in 
human serum at 250C and pH 7.4. Influence of preincuba­
tion with other organophosphorus compounds. Serum is pre­
incubated at 250C during 18 h. Percent of total remaining 
soman ел4и4 time. Organophosphorus concentration for 
preincubation (2 μΜ) ; О, no preincubation; · , 
C(±)P(±)-soman; •, paraoxon; A, pinacolyl dimethylphosphi-
nate. 
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Preincubation of serum with paraoxon, however, produces a 
similar change in the degradation time course, as after 
preincubation with soman. 
111.3.3. Hydrolysis of soman in serum ultrafiltrate. 
The contribution of spontaneous hydrolysis to the de­
gradation of soman in serum was evaluated by using serum 
ultrafiltrate. Figure III-7 gives the decrease of the 
first and second peak of soman елш* time for 30,000 NMWL 
(a) and 100,000 NMWL (b) respectively. The sera or their 
ultrafi Urates were not preincubated. For each peak the 
initial rapid fall of the concentration is no longer pre-
— ι — 
20 40 MIN 
Figure III-7 : Hydrolysis of C(±)P(±)-soman (50 nM) in 
serum ultrafiltrate at 250C and pH 8.8. Percent remaining 
soman V&7.-ÍU4 time. Open symbols : first eluting peak, 
containing C(-)P(+)- and C(+)P(-)-isomerá. Filled symbols: 
second eluting peak containing C(+)P(+)- and C(-)P(-)-iso-
mers. 
О and·, NMWL of 30,000; D andB, NMWL of 100,000; 
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sent, I.e.. , the biphasic behaviour, obtained in preincu-
bated serum, has disappeared. It can also be inferred 
that, for both ultrafiltrates, a distinct difference in 
hydrolysis rates exists between the two soman peaks. This 
is accounted for by thermodynamic differences existing be-
tween the epimers. The rate constants for the hydrolysis 
of the isomers of soman in serum ultrafiltrate were 
calculated (table III-3). 
111.3.4. Hydrolysis of soman In preincubated serum. 
It can be assumed that in preincubated serum both en-
zymatic and spontaneous hydrolysis will take place. The 
hydrolysis curves are shown in figure III-8, at pH 8.8 and 
pH 7.4 respectively. The reference point (100 %) at time 
zero is experimentally determined. The figure shows that 
TABLE III—3 : Rate constants for the hydrolysis of 
C(±)P(±)-soman (50 nM) in human serum ultra-
filtrate at 250C and pH 8.7 - 8.8. 
Normal molecular weight C(+)P(-) C(+)P(+) 
limit (NMWL) C(-)P(+) c(-)P(-) 
30,000 0.014±0.002 0.022±0.003 
100,000 0.031±0.004 0.048±0.005 
± 95% confidence limits. 
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10 20 30 40 
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Figure III-8. : Hydrolysis of C(±)P(±)-soman (50 nM) in 
preincubated human serum at 250C. Percent remaining soman 
ел4и.4 time. Square symbols : first eluting peak, 
containing the C(+)P(-)- and C(-)P(+)-isomers. Circle 
symbols : second eluting peak, containing the C(+)P(+)-
and C(-)P(-)isomers. · and H, pH e.7 -- 8.8; О and D, pH 
7.4. The curves are resolved according 
residuals and the best fitting is 
regression. Each point represents the 
determinations; fitting was done 
determinations. 
to the method of 
done by linear 
mean of 3 to 4 
using all the 
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both peak 1 and peak 2 disappear in a biphasic fashion, 
allowing the resolution of four linear processes by the 
graphical method of residuals and the calculation of four 
rate constants (table III-4). The four stereoisomers of 
soman are hydrolyzed at different rates. To verify the 
first order character of the total hydrolysis for each 
isomer, the rate constants are determined at pH 8.8 for 
various initial soman concentrations. The degradation 
curves obtained were similar to those represented in 
figure III-8. The results are shown in table III-5. At 
95 % confidence level no significant difference is found. 
TABLE III-4 : Rate constants of soman isomers for the 
combined hydrolysis processes of C(±)P(±)-
soman in preincubated human serum at 25°С. 
Temp pH Hydrolysis rate constant (min ) 
(0C) C(+)P(+) C(+)P(-) C(-)P(+) C(-)P(-) 
25 8.7-8.8 - 0.030±0.004 0.75±0.24 0.050±0.003 
25 7.4-7.6 - 0.009±0.004 0.47+0.11 0.019±0.003 
0 8.7-8.8 1.0+0.4 -
± 95% confidence limits. 
preincubation with 2.5 μΜ C(±)P(±) soman for 17 h at 
250C. 
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TABLE III-5 : Influence of initial concentration on the 
hydrolysis rate constants of three isomers 
b 
of soman in preincubated human serum at 
250C and pH 8.7 - 8.8. 
C(±)P(±) initial 
Hydrolysis rate constant (min ) 
concentration 
(nM) C(+)P(-) C(-)P(-) C(-)P(+) 
50 0.030±0.004 0.050+0.003 0.75±0.24 
500 0.028±0.003 0.047±0.003 0.82±0.31 
5000 0.028±0.005 0.048±0.004 0.57±0.32 
a ± 95% confidence limits. 
b 
preincubated with 2.5 μΜ soman during 17 h at 250C. 
111.4. DISCUSSION. 
From previous studies with phosphonofluoridates and 
phosphorofluoridates and from the degradation curves we 
obtained, it becomes clear that the fate of soman in serum 
should be composed of mainly three processes : (1) 
irreversible protein binding or phosphonylation (Polak and 
Cohen, 1970), (2) spontaneous hydrolysis and (3) enzymatic 
hydrolysis (Cohen and Warringa, 1957). 
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The imporLance of irreversiole protein binding as an 
aid in detoxification has been mentioned by others. 
Aliesterase in rat serum can account for the higher tole­
rance of these species towards nerve agent intoxication 
(Fonnum and Sterri, 1981). In human serum the inhibition 
of pseudoCholinesterase will lead to an occupation of 
about 8Q nM of phosphonylation sites (Myers, 1952); the 
relative value of this contribution to the total concen­
tration of phosphonylation sites will be discussed in 
chapter V. Other serum proteins are also capable of bin­
ding certain organophosphates : DFP was shown to bind 
irreversibly to serum albumine fractions (Murachi, 1963) 
and sarin to thrombin and pi asmi η (Mounter e¿ αλ , 1963). 
Phosphonylation in human serum is a relatively impor­
tant process at low initial soman concentrations. This is 
illustrated by the initially rapid decrease of soman, at 
50 nM, in non-preincubated serum (figure III-3). The in­
fluence of pH (figure III-4) may suggest that proteins are 
involved in the degradation reactions. The curves obtai­
ned by increasing the preincubation concentration suggest 
a saturable system (Figure III-5). 
Obviously, preincubation of serum with a sufficient 
amount of soman leads to a saiuration of binding sites; 
the remaining soman is then destioyed by hydrolysis. When 
the serum pri is decreased from 3.8 to 7.4 the preincuba­
tion concentration, needed for saturation, drops from 2.5 
to 0.5 μΜ. 
When paraoxon is used for the preincubation experi­
ments, the soman degradation curve becomes nearly identi­
cal with the degradation curve obtained in serum preincu-
bated with soman (figure III-6). This indicates that the 
binding sites are not soman-specific. Phosphylation sites 
would thus be a more appropriate name. 
Preincubation with pinacolyl dimethylphosphonale, a com­
pound without a reactive leaving group, apparently does 
not lead to phosphylation of the binding sites, yielding a 
degradation curve similar to the one in not-preincubated 
serum (figure III-6). Preincubation experiments with so­
man, paraoxon and pinacolyl dimethylphosphinate thus 
suggest that the reaction at the binding sites might occur 
in the same way as described for serine hydrolases (Horner 
and Flemming, 1985). 
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For total soman, the hydrolysis time course behaves 
in a biphasic way (fig III.5., ). In agreement with pre­
vious observations of Christen with sarin (Christen, 
1967), we suggest that this is due to a rapid breakdown of 
the P(+) isomers and a much slower degradation of the P(-) 
isomers. Benschop e.t al (1981a) demonstrated that, on a 
carbowax column, the first chromatographic peak of soman 
is composed of the C(+)P(-) and C(-)P(+) isomers and the 
second peak of the C(+)P(+) and C(-)P(-) isomers. The bi­
phasic disappearance of the two peaks in serum can be used 
to quantify the degradation rate of each of its components 
separately. At the experimental conditions mentioned, the 
C(+)P(+)-isomer hydrolyzes so fast that only a lower limit 
of its rate constant can be given. This limit is based on 
experiments at 0oC, that allow a resolution of the rate 
constant of the C(+)P(+)-isomer, its value being 1.0 
( ±0.4) min" 1 (table III.4.). The k-values are in 
accordance with the qualitative in ^Ыо observations of 
Benschop estai (1984b), who examined the hydrolysis in 
mouse plasma of a much higher soman concentration (1 mM) 
at which phosphylation becomes a negligible phenomenon. 
It has been stated previously that phosphorylphospha-
tase in serum behaves differently from hog kidney phospho-
rylphosphatase (Mounter, 1963). The k-values, for the 
P( + ) isomers are in some contrast with the qualitative 
enzymatic degradation curves of the four stereoisomers of 
soman in purified phosphorylphosphatase from hog kidney 
(Nordgren &t al> 1984). In human serum the difference 
between the rate constants of the P( + ) isomers is more 
marked. 
A comparison between tables III-3 and III-4 shows 
that, for the P(-) isomers, the enzymatic hydrolysis rate 
constants are in the same order of magnitude as the non 
enzymatic rate constants, whereas for the P(+) isomers the 
non-enzymatic part of the hydrolysis is almost neglegible 
at the pH studied. This is in accordance with the 
reported high selectivity of phosphorylphosphatase for the 
P( + ) isomer of sarin (Christen e-^  al, 1967). 
A decrease in pH results in a reduction of the к va­
lues. For the C(-)P(0 isomer this reduction should be 
almost exclusively attributed to a pH effect on enzyme ac-
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tivity. The drop in spontaneous hydrolysis with pH, as 
reported by Franke (1978), will only marginally affect 
P(+)-degradation, but can be expected to be relatively 
more important for P(-). 
The ultrafiltrate at 30,000 NMWL can be considered as 
essentially deproteinated. I.e.. no enantioselective effect 
is to be expected and the antipodes should behave identi-
cally. The epimers show linear degradation plots (figure 
II1-7) that go through the 100 % point at zero time. In 
the ultrafiltrate at 100,000 NMWL, albumin and some other 
proteins of lower molecular weight, are still present. It 
can be seen that extrapolation to zero time of the linear 
semi-log plot does not go through the 100 % point. This 
could be due to some irreversible binding in the 100,000 
NMWL fraction (see chapter V.). 
From the difference in hydrolysis rates between both 
ultraf i Urates (table III-3) it is clear that some pro-
teins, probably albumin (Erdös and Boggs, 1961), may have 
a catalytic effect, which might be stereoselective, 
rendering the assumption (Table III-3) that the enan-
tiomers C( + )P(-) and C(-)P( + ) as well as C( + )P( + ) and 
C(-)P(-) behave identically in 100,000 NMWL ultrafiltrate 
incorrect. This will be further investigated with 
C(+)P(±)- and C(-)P(±)-soman (see Chapter IV). 
In conclusion we showed that the degradation of soman 
in serum consists of mainly two processes, hydrolysis and 
phosphonylation. In the following chapter some aspects of 
the various hydrolysis reactions will be studied. 
Phosphonylation is treated in more detail in chapter V. 
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CHAPTER IV 
STEREOSELECTIVE HYDROLYSIS OF SOMAN IN HUMAN PLASMA AND 
SERUM. 
I V.l. INTRODUCTION. 
In the previous chapter some aspects of the enzymatic 
hydrolysis of soman were studied in preincubated serum 
using C(±)P(±)-soman. The differentiation between the 
isomers was based on a chromatographic separation of 
diastereoisomers and on a kinetic analysis of the stereo­
selective enzymatic hydrolysis. Experiments with serum 
and serum ultrafiltrate allowed to distinguish between a 
protein-catalysed hydrolysis and a spontaneous hydrolysis. 
In this chapter the use of C( + )- and C(-)-epimers 
will allow us to determine the hydrolysis rate constants 
of each isomer directly. This method will be compared 
with the indirect method using C(±)P(±)-soman as described 
in the previous chapter. Moreover, the relative importan­
ce of spontaneous елші enzymatic hydrolysis will be in­
vestigated and the kinetics of the hydrolysis processes in 
human serum or plasma, in various serum fractions and in 
buffer solutions will be studied. More in particular, ef­
fects of temperature and pH will be investigated and the 
influence of some divalent metal ions and other candidate 
inhibitors will be determined. 
For some experiments long hydrolysis times (> 30 min) were 
required and therefore buffered plasma or serum was used. 
IV.2. MATERIALS AND METHODS. 
IV.2.1. Materials. 
C(+)P(±)- and C(-)P(±)-soman were obtained from the 
Prins Maurits Laboratory, TNO, The Netherlands, with a pu­
rity > 98.5% for C(+)P(±) and > 99.2% for C(-)P(±); opti­
cal rotation ( a ^ J was + 14.4° for C( + )P(±)- and - 14.8° 
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for C(-)P(±)-soman. The synthesis of C(±)P(±)-soman was 
described in chapter II. 
The following serum fractions were used : human serum 
albumin (crystallized and lyophilized) and human serum 
Fraction IV-1 (essentially globulin free), both from Sig­
ma. Solutions of bivalent ions were obtained by dissol­
ving the corresponding chlorides in distilled water. 
All inorganic chemicals and solvents were of analyti­
cal grade. 
Human plasma was obtained by sampling blood from a 
venous puncture in tubes containing lithium heparin as an 
anticlot; the tubes were centrifuged and the collected su­
pernatant was pooled. Fractions of 5-10 ml were prepared 
immediately and stored at - 180C. Pooled human blood se­
rum was obtained as described in the previous chapter. 
Human serum ultrafiltrate was prepared from thawed serum 
using a pressurized 43 - or 25 mm stirred cell and a fil­
ter with a molecular weight cut-off of 30,000. 
To stabilize the pH in some experiments various buf­
fer solutions were used : Tris buffer was prepared with 50 
mM of 2-amino-2-hydroxymethyl-l,3- propanediol. Phosphate-
buffer was prepared from potassium dihydrogenphosphate 
(8.7 mM) and disodium hydrogenphosphate (30 mM). Buffers 
were adjusted to the desired pH with a 10 % NaOH or HCl 
solution in distilled water. 
Prior to the experiments frozen plasma or serum was 
allowed to thaw in a water bath at room temperature and 
centrifuged to remove cryoprecipitate, if present. Where 
necessary dilutions were made and/or metal ions or other 
effectors were added. Addition was done from solutions in 
water (2-propanol for the organophosphorus compounds). 10 
to 50 μΐ of solution were added per ml of serum or serum 
dluate. The pH was then adjusted to 7.4 with a 10 % HCl 
solution. Durino the experiments the pH did not change by 
more than 0.2 units. 
IV.2.2. Degradation experiments and assay. 
Were performed as described in the previous chapters. 
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IV.2.3. Calculation of hydrolysis rate constants. 
The indirect method was described in Chapter III. The 
direct calculation from C(+)P(±)- or C(-)P(±)-soman was 
done using the plot of the logarithm of the percentage re­
maining soman-isomer елш4 time using linear unweighted 
curve fitting. For each experiment, the 95 % confidence 
level was determined from the estimated variance of the 
slope (Natrella, 1963). 
IV.3. RESULTS AND DISCUSSION. 
IV.3.1. Spontaneous hydrolysis. 
It is shown in Table IV-1 that hydrolysis of the dia-
stereoisomers of soman in Tris buffer occurs at a diffe­
rent rate accounting for the differences in interatomic 
distances (intramolecular) which exist between diastereo-
isomers and which result in a different energy content for 
each of both diastereoisomers. Between enantiomers no dif-
TABLE IV-1 : Rate constants of spontaneous hydrolysis of 
soman in various media at 370C and pH 7.4. 
C(+)P(-) C(+)P(+) 
C(-)P(+) C(-)P(-) 
Phosphate buffer 0.0314±0.0035 0.0352+0.0016 
Тгіь-buffer 0.0032±0.0016 0.0040+0.0019 
min ; ± 95% confidence interval. 
C(±)P(±)-soman (50 nM, initial concentration). 
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ference is found. At pH 7.4 the rate constants in Tris 
are rather small and accordingly the standard errors of 
the slopes become proportionnaily larger. Consequently the 
difference between the rate constants of the diastereoiso-
mers is only significant at a level of confidence interval 
of 85 %. The C{+)P(+)-, C(-)P(-)-isomers are hydrolyzed 
at a higher rate than the corresponding C(+)P(-)-, 
C(-)P( + )-pair and this also holds for the hydrolysis in 
phosphate buffer. In agreement with observations by Ben-
schop et al (1985) it is found that the hydrolysis rate is 
enhanced by phosphate ions, as shown by the higher hydro-
lytic activity in phosphate buffer. 
TABLE IV-2 * 'ydrolysis rate 
b 
constants of C(±)P(±)-so-
an (50 M) in Tris-buffer at pH 7.4 and for 
various temperatures. 
T(K) C(+)P(-) 
C(-)P(+) 
C(+)P(+) 
C(-)P(-) 
304 
310 
314 
320 
323 
0.0024 ± 0.0010 
0.0032 ± 0.0016 
0.0036 ± 0.0012 
0.0058 ± 0.0018 
0.0093 ± 0.0021 
0.0028 ± 0.0014 
0.0040 ± 0.0019 
0.0047 ± 0.0016 
0.0076 ± 0.0018 
0.0110 ± 0.0025 
min ; ± 95% confidence interval, 
Control experipentr- Uöing Cd ~'{л-)~ and C(-)P(±)-soman 
allowed the determinaîion of the rate constants of the 
four isomers separately : all values obtained were found 
to be within the corresponding 95 % confidence interval. 
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Table IV.2. gives the temperature dependency of the 
hydrolysis of the soman diastereoisomers in Tris buffer. 
The activation energy, Ea, was calculated by plotting In к 
against 1/T (see Figure IV-1) according to the Arrhenius 
equation : 
- E /RT 
к = к e
 a 
о 
where к is the rate constant, к the preexponential fac­
tor, R the universal gas constant, and Τ the absolute tem­
perature. The values of the activation energy of the 
reaction, obtained from Figure IV-1, are 55 ± 13 kJ/mol 
for C(-)P( + ) and C( + )P(-), and 57 ± 8 kJ/mol for C( + )P( + ) 
and C(-)P(-) (table IV-3); both values do not differ sig-
TABLE IV—3 : Activation energies for the hydrolysis of 
b 
soman stereoisomers. 
C(+)P(-) C(+)P(+) C(-)P(+) C(-)P(-) 
Plasma/Tris 52 (12) 34 (3) 35 (3) 58 (9) 
Tris 55 (13) 57 (8) 55 (13) 57 (8) 
Fraction 
IV-1/Tris - 54 (11) 
kJ/min ; within brackets 95 % confidence interval; ob­
tained from the Arrhenius-plot (Figure IV-1). 
C(+)P(±)-I C(-)P(±)-soman is used with Plasma/Tris; 
C(±)P(±)-soman is used with Tris. 
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Figure IV-1 : Temperature dependence of spontaneous hydro­
lysis rate constants of soman in Tris, using C(±)P(±)-so-
man, (Δ and A ) , and of enzymatic hydrolysis in preincuba-
ted human plasma/Tris (50 % v/v), using C(+)P(±)- and 
C(-)P(±)-soman (D, Ш , О a n d · ) . 
The pH was kept at 7.4 - 7.6. 
• - C( + )P( + ); D-C(-)P( + ); #-C(-)P(-); o-C( + )P(-). 
A- first peak containing C(-)P(+) and C(+)P(-); Δ- se­
cond peak conbaining C(-)P(-) and C(+)P(+). 
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nificantly. Larsson (1957) found an Ea value of 38 kJ/mol 
for the hydrolysis of sarin at pH 9. This Ea-value is much 
lower than the corresponding values for the soman isomers. 
An explanation may be found by considering steric factors 
of the bipyramidal transition state complex. Steric hin-
drance will be more important for pinacolyl than for 
isopropyl and the resulting transition state complexes may 
differ in energy content. 
IV.3.2. Enzymatic hydrolysis. 
IV.3.2.1. Determination of hydrolysis rate constants. 
The use of partly resolved soman. I.e.. C( + )P(±)- and 
C(-)P(±)-soman allows the direct calculation of hydrolysis 
rate constants as, in this case, a chromatographic peak 
corresponds to only one isomer (Figure II-4 and Table 
II-l). The time course of the degradation of soman in 
preincubated human plasma then gives straight lines from 
which the hydrolysis rate constants can be calculated (Fi-
gure IV-2). A comparison can be made between results ob-
tained with C(+)P(±)- and C(-)P(± )-soman and those obtai-
ned with C(±)P(±)-soman. At 250C and a pH of 7.4-7.6 the 
hydrolysis of C(±)P(±)-soman in human plasma/Tris gives 
two biphasic curves (Figure IV-3), corresponding to the 
hydrolysis of the diastereoisomers in the same way as 
found for incubated human serum. Using the method of resi-
duals the rate constants can be calculated for the four 
isomers as explained in the previous chapter. Table IV-4 
gives the results obtained with the indirect and the di-
rect method on the same batch of human plasma/Tris. It is 
seen that there is no difference (at the 95 % confidence 
level) between the values obtained with the two methods. 
IV.3.2.2. Hydrolytic activity of serum fractions. 
Table IV-5 shows that the hydrolysis rates of the 
four isomers of soman in 0.2 % fraction IV-1 in Tris do 
not differ from their rate constants obtained in Tris (Ta-
ble IV-1). Addition of Ca + +, at the concentration level 
found in serum (5 mEq/L; Harper e¿ al, 1979), gives an en-
hancement of the hydrolysis especially for the C(+)-epi-
mers; addition of Mg++ does not have an influence at the 
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Figure IV-2 : Hydrolysis of soman in preincubated human 
plasma/Tris (50% v/v) at pH 7.4 - 7.6 and 370C. Soman 
epimers were used : C( + )P(±) 103.4 ng/ml (568 nM) and 
C(-)P(±), 101.3 ng/ml (556 nM) were used. 
• - C( + )P(-); O- C(-)P(-); •- C(-)P( + ). Each point re­
presents the mean of at least two determinations. The 
C(+)P(+)-isomer is hydrolyzed too fast to be shown on this 
figure. 
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Figure IV-3 : Hydrolysis of soman in preincubated human 
plasma/Tris (50% v/v) at pH 7.4 - 7.6 and 250C. C(±)P(±)-
soman was used : O -» first peak, representing C(+)P(-) 
and C(-)P(+); #-, second peak, representing C(+)P(+) and 
C(-)P(-). Each point is the mean of at least two determi­
nations. 
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TABLE IV-4 : Hydrolysis rate constants of the four iso­
mers of soman (50 mM) in preincubated human 
plasma C; diluted with Tris (50 % v/v), at 
250C and pH 7.4. 
Soman C(+)P(-) C(+)P(+) C(-)P(+) C(-)P(-) 
C(±)P(±) 0.0057 2.5 0.258 0.0102 
(0.0005) (0.6) (0.022) (0.0005) 
C(+)P(±) 0.0066 
(0.0009) 
2.1 
C(-)P(±) 0.248 
(0.010) 
0.0102 
(0.0008) 
a — 1 
min ; within parentheses are the 95 % confidence inter­
vals. 
b
 With 1 μ M C(±)P(±)-somanf 25
0C, 17 h. 
C(±)P(±)-soman was added and the rate constants 
calculated as explained in chapter III. C(+)P( ±)- or 
C(-)P(±)-soman was added and the rate constants calcula­
ted as explained in this chapter (see also Figure IV-2). 
By extrapolation of the Arrhenius plot (Figure IV-1) 
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TABLE IV-5 : Influence of the addition of ions upon the 
a b 
hydrolysis rate constants of soman in se­
rum fraction IV-1, 0.2% (w/v) in Tris; pH 
7.4, 370C. 
C(+)P(-) C(+)P(+) C(-)P(+) C(-)P(-) 
0.0028 
(0.0018) 
0.0061 
(0.0024) 
0.0027 
(0.0019) 
0.0037 
(0.0017) 
+ • с Ca 
_ +• с ++ d Ca , Mg 
0.0073 
(0.0013) 
0.0062 
(0.0031) 
0.0118 
(0.0012) 
0.0153 
(0.0035) 
0.0046 
(0.0012) 
0.0048 
(0.0020) 
0.0056 
(0.0013) 
0.0068 
(0.0020) 
Ca + + e 0.0084 
(0.0020) 
0.0173 
(0.0035) 
а . -1 
min ; within parentheses are the 95 
intervals. 
% confidence 
C(+)P(±)-, C(-)P(±)- soman is used. 
0.2 % (w/v) in Tris; pH 7,4, 370C. 
2 mM. 
1 mM. 
10 тМ. 
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95 % level of confidence. Increasing the Ca + + concentra­
tion to 20 mg Eq/L results in a slight increase of the 
rate of the C(+)P(+)-isomer. 
The hydrolysis rates of soman in human serum albumin 
solution are given in Table IV-5. It is seen that there 
isa catalytic effect for all four isomers, the effect be­
ing slightly superior for C(+)P(+). When albumin is dilu­
ted in serum ultrafiltrate, the rate constants further in­
crease. This effect can be attributed to some catalytic 
effect of the ionic environment, I.e.. phosphate ions, that 
is characteristic for serum ultrafiltrate. 
TABLE IV-6 : Hydrolysis rate constants of C( + )P(±)- and 
C(-)P(±)-soman (50 mM) in human serum albumin 
solutions, pH 7.4 and 370C. 
C(+)P(-) C(+)P(+) C(-)P(+) C(-)P(-) 
Serum albu-
min/Tris 
(2% w/v) 
О.0080 
(0.0011) 
0.0119 
(0.0007) 
0.0080 
(0.0011) 
0.0090 
(0.0009) 
Serum albu­
min/serum 0.0099 
ultrafiltrate (0.0017) 
(4% w/v) b 
0.0138 
(0.0017) 
0.0098 
(0.0014) 
0.0141 
(0.0014) 
a — 1 
min ; within parenthesis are the 95% confidence inter­
vals. 
Tris serum albumine/serum ultrafiltrate (30.000 NMWL) 
solution is further diluted to 50% (v/v) with Tris. 
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CD TABLE IV-7 . Hydrolysis rate constants (min ) of C(+)P(±)- and C(-)P(±)-soman 
(50 nM) in various media, at 370C and pH 7.4 - 7.6. 
C(+)P(-) C(+)P(+) C(-)P(+) C(-)P(-) 
Plasma/Tns 0.0160 
± 0.0050 
3.8 0.446 
± 0.0058 
0.0270 
± 0.0055 
Tris 0.0033 
± ο.υοιο 
0.0040 
± 0.0022 
0.0030 
± 0.0015 
0.0040 
± 0.0015 
Albumin/Tris 0.0080 
± 0.0011 
0.0119 
± 0.0007 
0.0080 
± 0.0011 
0.0090 
0.0009 
Fraction IV-1 d /Tris e 0.0073 
± 0.0013 
0.0118 
± 0.0012 
0.0046 
+ 0.0012 
0.0056 
± 0.0013 
50 % (v/v). 
Obtained by extrapolation (Arrhenius plot) of values at lower temperatures, 
C
 2 % (w/v). 
d
 0.5 % (w/v). 
e
 2.3 mM Ca + +. 
IV.3.2.3. Hydrolysis of soman isomers in human plasma or 
serum. 
IV.3.2.3.1. Evaluation of the contribution of serum frac­
tions to total hydrolysis of soman in plasma. 
From Table IV-7 it can be seen that in plasma, dilu­
ted with Tris, the P( + )-isomers are much more rapidly hy-
drolyzed than their P(-)-counterparts. As compared with 
their hydrolysis in solutions containing whole plasma, the 
hydrolysis of P(+)-isomers in solutions containing plasma 
fractions IV-1 or albumin is negligible even at 370C. The 
hydrolysis of the P(-)-isomers, however, is of the same 
order of magnitude in all the forementioned solutions. 
These findings confirm the selective hydrolysis of the 
P(+)-isomers in plasma. The P(-)-isomers are only slowly 
hydrolyzed. The contributions of fraction IV-1 and 
albumin account for a major part of the hydrolysis of the 
C(+)P(-)-isomer, which is hydrolyzed more slowly than its 
C(-)P(-)-counterpart. For the latter isomer the contribu­
tions of fraction IV-1 and albumin in the total hydrolysis 
process are proportionately smaller than for the C(+)P(-)-
isomer. 
IV.3.2.3.2. Temperature dependence. 
In experiments with serum ultrafiltrate (Chapter III) 
it was already demonstrated that a protein-connected me­
chanism is responsible for the high hydrolysis rate con­
stants of the P(+)-isomers in serum . Indeed, the rapid 
degradation of P(+)-isomers does not occur in serum ultra-
filtrate. In addition an enzymatically catalyzed hydroly­
sis should result in a lower activation energy as compared 
with the spontaneous hydrolysis process. 
An Arrhenius-plot for the hydrolysis of the four 
stereoisomers of soman in plasma/Tris is shown on Figure 
IV-1. Calculation of the slopes from a linear regression 
of In к = f (1/T) allows the determination of the activa­
tion energies, Ea, according to the Arrhenius-equation 
(see section IV.3.1.). 
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The results are shown in Table IV-3 : In plasma/Tris 
the activation energy is significantly lower for the hy­
drolysis of the P(+)-isomers than for the P(-)-isomers. In 
addition it is shown that, for the P(-)-isomers, there is 
no difference between activation energies of hydrolysis in 
Tris and in plasma/Tris. Thus, in plasma, the P(+)-iso-
mers are selectively hydrolysed according to an enzymatic 
mechanism with a correspondingly lower activation energy. 
Further experiments were done in undiluted plasma with 
C M - and C(-)-soman at pH 7.2 to 7.5 and at various 
temperatures; similar values for the activation energies 
were found. I.e. for C(-)P( + ) 32 ± 3 kJ/mol and for 
C(+)P(+) 32 ± 5 kJ/mol. In undiluted human serum and at a 
pH 8.7 to 8.8 the activation energy of C(-)P(+)-soman was 
calculated from к values obtained with the indirect 
method, using C(±)P(±)-soman. A value of 30 ± 9 kJ/mol 
was found. These findings indicate that a twofold dilution 
with Tris does not basically influence the enzymatic me­
chanism (Ea). The lower activation energy is not found for 
the P(-)-isomers, indicating a different mechanism as 
compared with the enzymatic hydrolysis of the 
P(+)-isomers. 
Indeed, the effect of a lower activation energy on 
the C(+)P(-)-isomer may be covered by the error of 
measurement, since the contributions of fraction IV-1 and 
albumin account for the major part of the hydrolysis in 
plasma/Tris, but for the C(-)P(-)-isomer, where 
contributions of fraction IV-1 and albumin are 
proportionally less important, the effect of a lowering of 
the activation energy by some 16 kJ/mol should be 
reflected in the Ea of the total hydrolysis, which is not 
seen on Table IV-3. This findings point towards important 
mechanistic differences between the hydrolysis in plasma 
of P(+)- and P(-)-isomers. Between plasma/Tris and Tris 
no difference in activation energy exists for the 
P(-)-isomers but the hydrolysis rate ro.ist-nts in plas-
r,ia/Tris are higher. This is explainable by a proximity 
effect (Page, 1984) of some serum proteins : they then 
play an important role by bringing reactants together 
without however lowering the energy of tne transition sta­
te. Thus a proximity effect will have an influence only 
on the entropy changes associated with the transition 
state. 
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It can be seen from table IV-6 that in serum fraction 
IV-1 the C(+)P(+)-soman is hydrolyzed more rapidly than 
the other isomers. This could be due to some wmana-ie. 
that precipitated with the serum fraction. If we then ac­
cept that a single tomanaie is hydrolyzing both P(+)-iso-
mers, a proportional effect could be expected for 
C(-)P(+). However, this effect, being some 10 times 
^ri + )p( + ) ^ r ( . ) p ( - ) ^ smaller than for C( + )P( + ), would not 
exceed the measurement error, and thus go unnoticed. The 
temperature dependence of the hydrolytic activity of frac­
tion IV-4 for C(+)P(+) (figure IV-6) allows the calcula­
tion of an activation energy of 54.0 ± 10.9 kJ/mol (Table 
IV-8), which is in the order of magnitude of activation 
energies found for non enzymatic hydrolysis of soman. It 
thus can be concluded that in fraction IV-1 a stereoselec­
tive proximity effect contributes to the hydrolysis of 
C(+)P(+)-soman. With regard to the effect of fraction 
IV-1 on the C(-)P(+)-isomer no conclusions can be drawn. 
MIN"' 
ζ 
< 
fc -05 
Ζ 
о 
υ 
ш 
< 
β 
01 
0032 .0033 0034
 κ
-ι 
Figure IV-4 : Temperature dependency of hydrolysis rate 
constant of C(+)P(+)-soman in a solution containing serum 
Fraction IV-1 in Tris at pH 7.4. 
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IV.3.2.3.3. Inhibition of catalytic activity. The role of 
Ca". 
The inhibition of hydrolytic activity was investiga­
ted primarily using preincubated human serum and racemic 
soman, quantified as the summation of four isomers. The 
results from previous paragraphs and from the literature 
made it clear that in serum a number of specific A-estera-
ses exists with overlapping catalytic activity. Some re­
ported properties of these A-esterases were indicative of 
the design of tests we carried out on "ютапсие " in order 
to determine some of its properties. Some A-esterases are 
inhibited by compounds which react with sulphydryl groups, 
suggesting that these SH-groups are needed to hold the en­
zyme in an active conformation; this was shown for a.o. 
CfP-ate. (Mounter e£ a-l, 1953) and tabunate. (Augustinsson 
and Heimburger, 1955). lodoacetate, a known SH-inhibitor, 
hardly inhibits the activity of somanase, even at O.IM 
(Table IV-8). The conclusion that, in this respect, ooma-
/гаое behaves not as most A-esterases is obvious : either 
no SH-groups are present or they do not play a fundamental 
role in the enzymatic process. The use of 8-hydroxyqui-
noline and ethylenediami ne tetraacetic acid (EDTA), both 
powerful complexants of divalent ions, clearly was more 
succesful. It can thus be concluded that divalent ions 
are necessary in the catalytic process. Aurin tricar­
boxylic acid ammonium salt (al umi non) on its own did not 
inhibit 'iom.ana'ie. activity, but, as reported by Erdös and 
Boggs (1961) for the hydrolysis of paraoxon, we found that 
the hydrolysis of soman was nearly completely blocked by a 
combination of EDTA and aluminon, both at the concentra-
tion level of 0.01 M (Table IV-9). 
The hydrolysis of phosphonate in human plasma is in-
hibited by EDTA (Becker and Barbaro, 1964) but it has not 
been proven to be an effect attribuable to the chelating 
of a particular ion. With C(+)P(±)- or C(-)P(±)-soman the 
hydrolysis of the P( + )-isomers can be determined in a di-
rect way. Figure IV-5 shows that the hydrolysis of both 
C(+)P(+) and C(-)P(+) are about complecely blocked with 
0.01 EDTA in preincubated human serum. When Ca++ was ad-
ded the activity returned, strongly suggesting that cal-
cium ions are in fact a co-factor of ютапсие.. 
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a b 
TABLE І -в : Influence of some inhibitors on the de-
gradation of C(±)P(±)-soman in preincuba­
ted human serum, pH 7.8 - 8.8; 250C. 
Inhibitor 
concen­
tration 
(mM) Control 
% remaining soman after 10 min 
lodoace- 8 OH-qui- EDTA Alumi-
tate noline non 
35 
1 
10 
100 
33 
36 
47 
37 
52 
93 
39 
78 
88 
32 
36 
37 
% remaining soman ± 95 % confidence limit after 10 min 
is compared with the control value (no inhibitor added) 
of 35 ± 8. 
Inhibitor added 60 min before start of degradation. 
50 nM initial concentration; C(±)P(±)-soman ( = sum of 
the two peaks) is determined. 
Preincubated with 2.5 μΜ racemic C(±)P(±)-soman at 250C 
during 17 h. 
Each value is the mean of at least two determinations. 
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TABLE IV-9 : Influence of the combination of EDTA/Alumi-
b с 
non on the hydrolysis of C(±)P(±)-soman 
in preincubated human serum, pH 8.7 - 8.Θ; 
250C. 
Aluminon 
(mM) 
EDTA 
(mM) 
% remaining C(±)P(±)-soman after 10 min 
0.1 1 10 
35 
1 
10 
100 
36 
36 
not de­
termined 
37 
40 
43 
74 
87 
95 
% remaining C(±)P(±)-soman (50 nM initial concentration) 
after 10 min is compared with the control value (no in­
hibitor added) of 35 (± 8, 95 % confidence limit). 
Added 60 min before the start of the hydrolysis experi­
ment. 
Total soman (= sum of the two peaks) is determined. 
Preincubated with 2.5 μΜ C(±)P(±)-soman; 17 h; 250C. 
Each value is the mean of at least two determinations. 
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Figure І -5 : Hydrolysis of soman in human serum at pH 7.4 
_ ? 
and 250C. Open symbols human serum + EDTA (10 M) ; fil-
led symbols human serum + EDTA (10 M) + Ca++ (10 M). 
O,· C( + )P( + ); D.M C(-)P( + ). 
IV.3.2.3.4. Influence of other divalent metal ions. 
According to a classification by Mounter (1963) Ba + 
and Sr + + ions activate serum phosphorylphosphatases where­
as Co + + and M n + + ions inhibit the enzyme activity. Table 
IV-10 show that as far as юталсме is concerned there is 
hardly any influence of Ba + +, Sr + +, Co + + and Mn + +. On the 
basis of these results wmanaie. cannot simply be classi­
fied as a non specific serumesterase (Mounter, 1963). Hg + + 
strongly inhibits the enzymatic hydrolysis of both 
C(+)P(+)- and C(-)P(+)-soman, which is in accordance with 
previously reported results on the hydrolysis of soman in 
serum (Christen, 1967). It is further shown that the hy­
drolysis of the P(-)-isomers is not significantly affected 
by Hg + +, in contrast with the important inhibition on the 
P(+)-hydrolysis. These results contribute to the state­
ment that with regard to the románate, -catalyzed hydroly-
sis, a fundamental difference exists between the mechanism 
applied to the P(+)- and P(-)-isomers, which was already 
concluded from the different activation energies (section 
IV.3.2.3.2.). 
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TABLE IV-10 : Influence of divalent metal ions (1 mM) on 
the hydrolysis of C(+)P(±)- and C(-)P(±)-so-
man (2.8 μΜ) in preincubated human serum 
(pH 7.4, 250C). 
Metal ions C(-)P(+) C(-)P(-) C(+)P(+) C(+)P(-) 
(1 mM) 
Co1 
Ba' 
Sr' 
Mn 
Hg' 
0.91 
0.99 
0.87 
0.83 
0.33 1.09 
0.94 
0.96 
0.99 
0.80 
0.20 0.82 
Expressed as k/k _, with к 
ref ref 
the first-order rate 
constant, without ions added, and k, the first-order 
rate constant with ions added. 
Preincubated with 2 yM of C(±)P(±)-soman at 250C, 17 h. 
IV.3.2.3.5. pH dependence. 
In paragraph IV.3.2.3.2. the question was raised 
whether the same enzyme hydrolyzes C(-)P(+)- and C(+)P(+)-
soman. Studies with mixed substrates cannot be used here 
because the high concentrations needed (0.01 M) can be ex­
pected to induce a rapid racemization due to the produced 
F . An evaluation of the pH dependency may well lead to 
some conclusion. Figure IV-6 shows the influence of pH on 
the first order rate constant of C(-)P(+) and C(+)P(+). It 
is seen that, in the pH-interval studied, the hydrolysis 
88 
of C(+)P(+) is practically unaffected by raising the pH 
whereas the hydrolysis of C(-)P(+) is enhanced. This dif­
ferent behaviour however does not lead to the unequivoqual 
conclusion that both compounds are hydrolyzed by a diffe­
rent enzyme. Since C(+)P(+)- and C(-)P(+)-soman are dia-
stereoisomers, it is foreseable that the optimal enzyme 
conformation will differ for both compounds. Conformatio­
nal changes due to a raise in pH may favour the hydrolysis 
of C(-)P(+)-soman. 
log к 
.5 
.5 
π g 
10 pH 
Figure IV-6 : pH dependence of the hydrolysis rate con­
stants of soman in human serum at250C. Filled symbols 
C(+)P(+); open symbols C(-)P(+). For each isomer two 
serum batches were used (squares and circles). 
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Figure IV-7 shows the pH stability of мтапсиг : the 
hydrolysis is done at pH 8 but the enzyme was incubated 
for 60 min at the pH indicated. It is clear from that the 
•iomanaie. is stable between pH 6 and 10.5 and that the 
bell shaped curves are similar for both substrates, 
C(-)P(+) and C(+)P(+). On the basis of these results it 
does not appear that they are hydrolyzed by different en­
zymes. A similar bell-shaped curve was found by Adi e 
(1958) for the hydrolysis of sarin in bovine plasma. 
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Figure IV-7 : pH dependency of the hydrolysis rate con­
stants of soman in human serum : the serum is kept at the 
pH indicated and at 25°C for 30 minutes and subsequently 
the hydrolysis rate constants are determined at pH 8 and 
250C. D - C( + )P( + ), • - C(-)P( + ). 
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IV.3.2.3.6. Comparison of hydrolysis rate constants in 
various serum pools and in some individual 
sera. 
It is seen on Table IV-11 that rather large differen-
ces exists between the sera obtained from various indivi-
duals, reflecting essentially a difference in enzyme con-
centration· since the substrate concentration is low enough 
to obtain first order kinetics. Between serum pools small 
differences are generally found (Table IV-12). Obviously 
TABLE IV-11 : Hydrolysis rate constants (min ) of 
C(-)P(+)- and C(+)P(+)-soman in preincubated 
individual human sera and of the four iso-
mers in one freshly prepared pool (^  40 
donors) at pH 7.4 and 250C. Each value 
represents the mean of at least two 
determinations. 
C(-)P(-) C(-)P(+) C(+)P(-) C(+)P(+) 
Individual Nr 
1 
2 
3 
4 
5 
0.451 
0.668 
0.504 
0.455 
0.217 
3.43 
6.37 
4 .11 
4.33 
1.70 
Freshly prepa-
red pool 0.0128 0.445 0.0050 4.24 
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the large number of blood donors, representing a pool, 
flattens the peak value. When both Tables IV-ll and IV-12 
are compared it is seen that the individual values and 
those obtained from a freshly prepared pool are generally 
higher. This might be explained by the fact that serum 
pools are normally collected over a period of three days; 
during this collection period storage occurs at 40C and 
some enzyme may degrade. 
TABLE IV-12 : Hydrolysis rate constants (min ) of soman 
epimers for various serum pools at pH 7.4 
and 250C. 
Pool C(+)P(-) C(+)P(+] 
A 0.302 a 2.87 a 
В 0.250 2.64 
С 0.277 2.75 C 
D 0.298 2.71 a 
E 0.347 a 3.72 a 
a 
D 
Mean of 2 determinations. 
Mean of 4 determinations. 
Mean of 3 determinations. 
92 
IV.4. SUMMARY ANO CONCLUSIONS. 
In whole preincubated serum or plasma the four iso-
mers of soman are hydrolyzed at a different rate; due to 
the low initial concentrations of soman first-order kine-
tics were obtained. This process consists of two phenome-
na, spontaneous hydrolysis and catalyzed hydrolysis. 
Spontaneous hydrolysis (in buffer) occurs at a faster rate 
for the 'equally signed' isomers, C(+)P(+) and C(-)P(-); 
between the enantiomers, no difference in hydrolysis rates 
exists. Serum fractions IV and V (albumin) were found to 
stereoselectively catalyze the hydrolysis of soman; in 
fraction V the C(+)P(+) and C(-)P(-) are hydrolyzed at a 
faster rate than their respective counterparts, while in 
fraction IV-1 a stereoselective effect towards C(+)P(+)-
soman is found. All the forementioned contributions are 
negligible with regard to the stereoselective enzymatic 
hydrolysis of the P(+)-isomers. This reaction is charac-
terized by a significant lowering of the activation energy 
as compared with the spontaneous hydrolysis of the 
P(+)-isomers. Such a lowering in activation energy is not 
found for the hydrolysis of the P(-)-isomers in whole 
serum or plasma; hence it can be concluded that a phospho-
rylphosphatase hydrolyzes the P(+)-isomers in a stereose-
lective way, the P(-)-isomers either not being affected by 
this (these) enzyme(s) or the mechanism of catalysis being 
fundamentally different for the P(-)- and the P(+)-isomers 
respectively. This conclusion is in agreement with the 
observations on the influence of Hg++ on the hydrolysis of 
soman in serum; the hydrolysis of the P(+)-isomers is sig-
nificantly inhibited by 1 nM of Hg++ while the P(-)-hydro-
lysis is unaffected by this ion concentration. 
Furtheron, the action of some potential inhibitors on 
this phosphorylphosphatase was studied. lodoacetate did 
not inhibit the enzyme and neither Ba + +, Sr + +, Co++ or 
Mn++ exist. On the other hand the hydrolytic activity in 
serum was nearly completely inhibited by EDTA but restored 
upon addition of Ca + . These findings do not allow the 
classification of these phosphorylphosphatase(s) according 
to the system of Mounter (1963) or Hoskin (1985) but sug-
gests that this enzymatic activity can be considered as 
belonging to an arylesterase (Erdös and Boggs, 1961). 
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Finally, the influence of pH on the hydrolytic acti-
vity which shows a different pattern for C(+)P(+)- and 
C(-)P(+)-soman, may suggest that more than one enzyme is 
involved in the degradation of soman. 
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CHAPTER V. 
IRREVERSIBLE BINDING OF SOMAN TO HUMAN SERUM PROTEINS 
(PHOSPHONYLATION). 
V.l. INTRODUCTION. 
It has been shown in Chapter III that part of the so-
man added to serum, is irreversibly bound to serum pro-
teins (phosphonyiation). Hitherto the phosponylation si-
tes in serum were saturated in order to prevent them from 
interfering with the hydrolysis processes. However 
phosphonyiation might be an important detoxification rou-
te, provided the concentration of sites is relatively im-
portant and a stereoselective effect, if present, favours 
the binding of the more toxic P(-)-isomers. 
In this chapter the following aspects of the phospho-
nyiation of human serum by soman are investigated : the 
concentration of phosphonyiation sites are estimated, 
using C U )P(± )-soman, by comparing degradation curves in 
preincubated human serum (I.e.. all sites occupied) and in 
not preincubated human serum (no sites occupied). The 
stereoselectivity of the phosphonyiation process is stu-
died, using C(+)P(±)- and C(-)P(±)-soman, by blocking the 
enzymatic hydrolysis process and by taking advantage of 
the fact that the P(-)-isomers are only slowly hydrolyzed. 
V.2. MATERIALS AND METHODS. 
Materials and methods used in this chapter are des-
cribed in the corresponding sections of the previous chap-
ters, except for the calculation of bimolecular second-or-
der rate constants. These are obtained by using the 
integrated equation (Jüngers, 1958, p. 79) : 
1 s(p - x) 
kt = In 
ρ - s p(s - χ) 
where s and ρ are the initial concentrations of soman iso­
mer and phosphonyiation sites, respectively, and χ is the 
concentration of soman isomer that has phosphonylated at 
time t. 
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V.3. RESULTS AND DISCUSSION. 
V.3.1. Degradation of C(±)P(±)-soman in human serum and 
plasma. 
V.3.1.1. Influence of initial soman concentration. 
It was shown in chapter III that preincubation of hu­
man serum with an organophosphorus compound possessing an 
adequate leaving group resulted in the saturation of bin­
ding sites. The existence of saturable binding can also 
be demonstrated when the degradation of soman, applied at 
various initial concentrations in not-preincubated human 
serum or plasma, is plotted елш* time. Figure V-1 shows 
Figure V-1 : Degradation of C(±)P(±)-soman in human plasma 
at pH 7.4 and 250C at various initial concentrations : 
Δ- 52 nM; A- 104 nM; D- 159 nM; •- 520 nM. 
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that the time course of the degradation is modified when 
the initial soman concentration is varied : when the ini­
tial concentration is raised the degradation curves become 
less steep which indicates that the contribution of a 
saturable binding compartment becomes relatively less 
important at the higher initial soman concentration. The 
rapid degradation at 52 nM as compared with that at 520 nM 
(initial concentration) indicates that the occupation of 
phosphonylation sites is, at least for some isomers, a 
fast process having a rate comparable with that of the 
enzymatic hydrolysis of the P(+)-isomers. 
V.3.1.2. Estimation of concentration of binding sites in 
human serum and plasma. 
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Figure V-2 : Determination of phosphonylation site - con­
centration in human plasma (a) and human serum (b) at 
250C, pH 7.4 and an initial C(± )P(± ) concentration of 520 
nM. The linear parts of degradation curves in preincuba-
ted (•, В and • ) and not preincubated (O, D and Δ ) samples 
are extrapolated to zero minutes. The obtained values are 
subtracted (#minusO, В minus Π and A minus Δ ) and the 
result {% of initial concentration) is multiplied by the 
initial concentration of soman to obtain the concentration 
of phosphonylation sites. A and Δ represent the degrada­
tion of C(±)P(±)-soman m human serum, treated with 
EDTA/aluminon (10 mM). 
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When the degradation curve of C(± )P(± )-soman at an 
initial concentration of 95 ng/ml (520 nM) in not-preincu-
bated human plasma is plotted as per cent remaining soman 
елш-і time and compared with the degradation of C(±)P(±)-
soman in preincubated human plasma, under identical condi­
tions it is seen that both curves become equidistant after 
some time (figure V-2-a). The extrapolation of this equi-
distancy to zero minutes allows the estimation of the per­
centage of initial concentration that, in not-preincubated 
plasma, will be responsible for the occupation of 
phosphonylation sites. It is seen that some 17 percent of 
the initial 520 nM is bound, which is an estimate of the 
concentration of phosphonylation sites, -L.e. 88 nM. Simi­
lar curves were determined in human serum (figure V-2-b) 
giving 92 nM. It appears that there is no significant 
difference between human plasma and human serum with re­
gard to the phosphonylation site concentration. 
Another way of estimating the binding site concentra­
tion is by comparing the degradation curves in not prein­
cubated serum and in preincubated serum in the presence of 
EDTA/aluminon (figure V-2-b, and ). It is seen that ex­
trapolating the linear portions gives 17.1 percent of the 
initial 520 nM, I.e.. 89 nM. Hence it can be concluded 
that treatment of human serum with EDTA/aluminon (10 mM) 
does not modify the concentration of phosphonylation si­
tes. 
Using the same method as in figure IV-2-a, the con­
centration of phosphonylation sites was determined also in 
the sera of some individuals. The results are shown in 
Table V-l. It is seen that the values are all within the 
same order of magnitude, with a mean of 73 nM. The 95 
percent confidence intervals were calculated from the va­
riation about the regression line. The additional uncer­
tainly that is due to the scattering of the 100 percent 
point is ruled out since for both preincubated and not-
preincubated serum the same reference values at zero minu­
tes are used. 
All values obtained were < 100 nM i ι contrast to an 
earlier reported value of 120 nM (De Bisschop &t al , 
1985b). This value was the result of an error in trans­
cription which was not detected during the review procedu­
re. 
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TABLE V-1: Concentration of phosphonylation sites (± 95% 
confidence limits) in the sera of some indivi­
dual humans, measured as explained in section 
V.3.2.I., Fig. V-2.a. 
Individual 
Nr 1 2 3 4 5 6 
Concentra­
tion phos- 56±15 79±16 68±13 93±16 57±16 87±14 
phonylation 
sites (nM) 
Mean value : 73 nM (standard deviation = 16 nM). 
V.3.2. Stability of phosphony1ated proteins. 
Serum proteins that are rapidly phosphonylated may 
play a role as organophosphorus antagonists by trapping 
them. In a way such proteins could act like a "sponge" 
(Karczmar, 1985). It is interesting to known whether the 
phosphonylated protein can splitt off the organophosphorus 
moiety as occurs in the reactivation of inhibited Cho­
linesterase. Despite their rather low concentration in 
human serum, an induced regeneration of the 
phosphonylation sites could present an additional 
possibility for prophylaxis against, and treatment of ner­
ve agent poisoning. 
A limited study of the stability in time of phospho­
nylated human serum proteins was done at various pH-va-
lues : human serum, preincubated with 1 μΜ C(±)P(±)-soman 
for 18 h at 250C and pH 7.4, was adjusted at pH 9.0, and 
7.4 respectively and allowed to stand at that pH for 
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another 24 h at 250C. Then the degradation of C(±)P(±)-so-
man was determined and the resulting curve, percentage 
remaining soman елш* time, compared with the reference 
curve, I. e. the degradation of soman in human serum prein­
cubated for only 18 h. On the other hand the degradation 
of soman in not preincubated serum gave an indication of 
the maximum effect that could be obtained. The results are 
shown in figure V-3. No difference was found between the 
different degradation curves, indicating a stable (irre­
versible) phosphonylation. 
100 г 
-ι-
8 16 MIN 
Figure V-3 : Stability with time of phosphonylated human 
serum proteins at 250C, as determined from the degradation 
of C(±)P(±)-soman (110 nM) in human serum at 250C and pH 
7.4, expressed as % remaining soman елші time; reference 
curve : · - all phosphonylation sites occupied (preincuba­
tion with 1 μΜ C(±)P(±)-soman, 250C, 18 h); • - preincuba­
tion for 41 h at 250C and pH 7.4, A - preincubation for 
17 h at 250C and pH 7.4 and subsequently for 24 h at 250C 
and pH 9.0. The degradation in non-preincubated serum 
(all phosphonylation sites unoccupied) is shown also : 0 . 
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An important "sponge1 effect can only be expected if 
rapid dephosphonylation could be induced by drug action, 
in much the same way as the oxime-induced reactivation of 
Cholinesterase; the -σι vivo renewal rate of proteins 
possessing phosphonylation sites is probably too slow to 
be of any importance in acute poisoning. A study of the 
reactivation and regeneration of these sites falls, how­
ever, outside the scope of the present investigations. 
V.3.3. Stereoselectivity of the phosphonylation of human 
serum proteins. 
V.3.3.1. First approach : Inhibition of somanase and ap­
plication of the model of competing reactions. 
When C(+)P(±)- or C(-)P(±)-soman is added to serum, 
treated with EDTA and/or aluminon, the enzymatic hydroly­
sis is blocked. Phosphonylation of serum proteins will be 
the main process. In principle competition between the 
soman epimers can be expected for this reaction. Due to 
the similarity between both isomers it can reasonably be 
assumed that the kinetic equations for the two competing 
reactions are identical, except that the values of the 
specific rate constants will differ. It is further as­
sumed that the phosphonylation sites are a homogeneous 
group and that the binding reaction is first order with 
regard to soman and phosphonylation sites. 
The following reaction equations can then be written (Jun­
gers, 1958) : 
Sj + Ρ * SjP (V-l) 
S2 + Ρ - S2P (V-2) 
with S and S representing the soman epimers and Ρ the 
phosphonylation sites. The corresponding rate equations 
car be written, with lower capitals to denote concentra­
tions. 
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d s i 
W 
ds 
kjSjP (V-3) 
2
 - к s ρ (V-4) ÏÏT - V 2 
(V-3) / (V-4) and rearranging gives : 
ds1 k1 dsi 
S2 4 S2 
The ratio of rate constants r = к /к can then be 
calculated from : 
kj logiSj/s^) 
^ log (s2/s°) 
where s0. and s0„ are the initial concentrations of the 
ι 2 
soman epimers s and s , respectively. From the fractions 
of epimer remaining at t the ratio к /к can be determined 
at any time t. Figure V-4 shows the results of a typical 
experiment. The values calculated are shown in Table V-2. 
The results are shown in Table V-2. It is seen that the 
P(-)-isomers phosphonylate more rapidly than their 
P(+)-counterparts. From Table V-2 mean values of the 
ratios of phosphonylation rate constants can be calcula­
ted: for ^ r i . ) p i
 + )^ri.)p(.) a niean v a l u e of 0·31 is 
found, and 0.15 for k
c ( + ) p ( + ) / k c ( + ) p ( _ ) . 
The ratios of phosphonylation rate constants, calculated 
in the previous paragraphs according to the theory of com­
peting reactions, can also be written as a set of two 
equations : 
kC(-)P(+) = 0 · 3 1 · kC(-)F(-) (V"5) 
kC(
+
)P(
+
) = 0 · 1 5 · kC(
+
)P(-) (v-6) 
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Figure V-4 : Degradation of C(-)P(±)- and C(-)P(±)-soman 
in not-preincubated human serum treated with EDTA/aluminon 
(10 mM) at 250C and pH 7.4, expressed as % remaining epi-
тег ел-зи-і time. Initial concentration of C( + )P(±)- and 
C(-)P(± )-soman is 110 nM. • - C( + )P( + )-soman; П - C( + )P(-)-
soman; A - C(-)P(-)-soman; Δ- C(-)P( + )-soman. 
TABLE V-2 : Mean values of the ratio of phosphonylation 
rate constants for C(-)- and C(+)-epimers in 
not preincubated human serum spiked with EDTA/ 
aluminon (10 mM final concentration). 
pH 7.4; 250C. 
Initial con­
centration 
of C(-)P(±) 
or C(+)P(±) 
(nM) 
110 
110 
55 
110 
110 
Human 
serum 
batch 
A 
A 
В 
С 
С 
C(-)P(+) 
*С(-)Р(-) 
СЫРЫ 
Ъ Ы Р Ы 
0.26±0.04 (9) 
0.25±0.01 (13) 
0.26±0.05 (7) 
0.41+0.13 (4) 
0.41±0.04 (3) 
0.19+0.04 (11) 
0.16±0.04 (11) 
0.12±0.01 (5) 
0.12±0.04 (6) 
0.14±0.08 (3) 
± standard deviation; within parenthesis the number of 
determinations. 
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Additional data are needed to estimate the phosphony-
lation rates of all four isomers, which will allow to 
establish a relative ranking. Such data are presented in 
section V.3.3.2. 
It can be argued that this method neglects spontane­
ous hydrolysis and supposes a complete blocking of the en­
zymatic hydrolysis of the P(+)-isomers; such effects of 
remaining hydrolysis would result in an overestimation of 
the ratios kp,
+
»/kn/_\. With regard to the remaining 
enzymatic activity, a complete blocking of the enzymatic 
hydrolysis with EDTA was shown in the previous chapter 
(Figure IV-5); the spontaneous hydrolysis rate constants 
are ± 0.01 min" ; whether this is negligible as compared 
with the phosphonylation rate constant will be discussed 
in section V.3.3.3.. 
V.3.3.2. Second approach : comparison of degradation rate 
constants In preincubated and not-preincubated 
human serum. 
Phosphonylation and hydrolysis will occur simultane­
ously in not-preincubated serum, whilst in preincubated 
serum hydrolysis will be the remaining process. Thus from 
the differences between initial rate constants in not-pre­
incubated and preincubated serum the initial phosphonyla­
tion rate constant can be calculated. Figure V-6 shows 
the degradation of C(-)P(±)- soman and C(+)P(±)-soman ел-
4U4 time in not-preincubated human serum. Qualitatively 
it is seen that, for C( + )P(-)- and C(-)P(-)-soman, some 
fifty percent of the isomer has degraded after 0.3 min and 
2 min, respectively. Hence it can be concluded that the 
P(-)-hydrolysis {соп.£.ел Figure IV-2) is a negligible pro­
cess compared with phosphonylation. The latter reaction 
is considered as a bimolecular reaction, first order with 
regard to soman and to binding sites (eqn V-l and V-2), 
which explains the deviation from linearity on the 
semi-log plots cf Figure V-5. For the P(+)-isomers hy-
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drolysis is important, due to the stereoselective enzy­
matic activity. However, if phosphonylation is not negli­
gible, a deviation from linearity should be detectable. 
Since this is apparently not so, it is predictable that, 
for the P(+)-isomers, phosphonylation is negligible as 
compared with the hydrolytic process. 
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Figure V-5 : Degradation of C(-)P(±)- and C(+)P(±)-soman 
in not-preincubated human serum (pH 7.4 and 250C). Initial 
C(+)P(±)- and C(-)P(±)-soman concentration : 164 nM (open 
symbols) and 110 nM (filled symbols). 
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TABLE V-3 Initial rate constants of total degradation of 
C(-)P(+)- and C(-)P(-)-soman in human serum 
and of phosphonylation of human serum proteins 
by C(-)P(+)- a and C(-)P(-)-soman b (pH 7.4. -
250C). 
Initial 
concentra­
tion of 
C(-)P(±)-
soman 
(nM) 
55 
55 
55 
110 
110 
110 
165 
165 
-
Batch 
A 
В 
С 
А 
В 
С 
В 
С 
Ci-
Total degra­
dation rate 
constant 
(min ) 
0.45 (±0.07) 
0.50 (±0.08) 
0.60 (±0.10) 
0.56 (±0.06) 
0.47 (±0.10) 
0.56 (±0.08) 
0.59 (±0.15) 
0.57 (±0.06) 
P( + ) 
Phosphonyla­
tion rate 
constant 
(mm ) 
0.07 
0.11 
0.13 
0.18 
0.08 
0.09 
0.20 
0.10 
C(-)P(-) 
Total degra-
dation(phos-
phonylation) 
rate 
constant 
(min-1 ) 
0.44 (±0.10) 
0.43 (±0.06) 
0.57 (±0.11) 
0.47 (±0.10) 
0.34 (±0.09) 
0.46 (±0.07) 
0.44 (±0.15) 
0.42 (±0.03) 
Obtained by subtracting the hydrolysis rate constants 
(in preincubated serum) from total degradation rate con­
stants (in not-preincubated serum); hydrolysis rate con­
stants obtained for various batches were : 
0.38±0.05, В : 0.39±0.04 and С : 0.47±0.06 min -1 
The hydrolysis rate constant for C(-)P(-)-isomer is 
0.012 min ; thus phosphonylation rate constants can be 
estimated from the total degradation rate constants. 
Within parenthesis the 95 % confidence limits. 
Transformed from bimolecular rate constants (Fig V-5) to 
initial pseudo first-order rate constants by multiplica­
tion with binding site concentration (73 nM). 
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TABLE V-4 : Initial rate constants of total degradation of 
C(+)P(-)- and C(+)P(+)-soman in human serum 
and of phosphonylation of human serum proteins 
by C( + )P(-)-soman b (pH 7.4 - 25"C). 
Initial 
concentra­
tion of 
C(
+
)P(±)-
soman 
(nM) 
C(+)P(+) 
Total degra- Phosphonyla-
dation rate tion rate 
constant 
Batch (min -1 
constant 
(min ) 
C(+)P(-) 
Total degra-
dation(phos-
phonylation) 
rate con-
+• 4- C d 
stant , 
(min ) 
55 
55 
110 
110 
165 
165 
В 
С 
В 
С 
В 
с 
4 . 2 ( ± 1 . 8 ) 
5 .3 ( ± 1 . 4 ) 
5.0 ( ± 1 . 8 ) 
5 .7 ( ± 1 . 3 ) 
5 .1 ( ± 0 . 8 ) 
5.9 ( ± 1 . 4 ) 
0 . 1 
0 . 7 
0 . 9 
1.1 
1.0 
1.3 
3 .0 ( ± 0 . 9 ) 
3 . 7 ( ± 0 . 7 ) 
2 . 5 ( ± 1 . 7 ) 
1.5 ( ± 0 . 5 ) 
2 . 5 ( ± 0 . 8 ) 
2 . 3 ( ± 0 . 5 ) 
Obtained by subtracting the hydrolysis rate constants 
(in preincubated serum) from total degradation rate con­
stants (in not-preincubated serum); hydrolysis rate con­
stants obtained for various batches were : 
В 
4.1±0.4 min 1 and С : 4.6±1.2 min -1 
The hydrolysis rate constant for C(+)P(-)-isomer is 
0.006 min , hence degradation rate constants are 
identical with phosphonylation rate constants. 
Within parenthesis the 95 % confidence limits. 
Transformed from bimolecular rate constants (Fig V-5) to 
initial pseudo first-order rate constants by multiplica­
tion with binding site concentration (73 nM). 
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Quantitative results are presented in Taoles V-3 and 
V-4. For С(-)?(±), Table -З snows thac the phosphonyla-
tion rate constants of C(-)P(+J-soman, calculated by sub­
tracting hydrolysis rate constants from total degradation 
rate constants (obtained in not-preincubated serum) are 
widely dispersed around a mean value of 0.12 min" with a 
95 percent confidence interval of 0.11 min . It is seen 
that the relatively small phosphonylation rate constant is 
of the same order of magnitude as the 95 percent confiden­
ce interval of the total degradation rate constant 
indicating a minor role of phosphonylation for P(+). For 
the C(-)P(-)-isomer the results are more straightforward. 
The hydrolysis rate constant, 0.012 min , is negligible 
as compared with the degradation rate constant; hence the 
latter can be substituted for the phosphonylation rate 
constant : a mean value of 0.45 min is found. The 
bimolecular rate constants of the pnosphonylation 
reactions are calculated as described in section V-2. 
Initial first-order rate constants are obtained by 
multiplication of bimolecular rate constams and 
concentration of phosphonylation sites. 
Similar results are found for C(+)P(±)-soman (Table V-4) : 
the phosphonylation rate constants obtained for C(+)P(+)-
soman completely disappear within the 95 percent confiden­
ce intervals of the total degradation rate constants. The 
C(+)P(-)-isomer is rapidly degraded. The contribution of 
hydrolysis (0.006 min - 1) is completsly negligible as 
compared with the degradation rate constants (mean value, 
2.6 min" ), which can be substituted for the phosphonyla­
tion "ate constant. 
Since the 95 percent confidence intervals of the 
phosphonylation rate constants of the P(+)-isomers are 
equal to or greater than their respective mean values, it 
can only be concluded that the rate constants differ from 
zero. The large 95 percent confidence intervals are due 
to the fact tha,, two ra:e constants of comparaole value 
are subtracted, resulting in a much smHler value. In 
addition, both rate constants show a large variation 
probably due to the short measuring ti,;ies (10 to 30 
seconds), wnich do not guarantee adequate mixing. 
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V.3.3.3. Stereoselectivity of phosphonylation : conclu-
sions. 
Phosphonylation of human serum proteins is a stereo-
selective process. The C(+)P(-)-isomer phosphonylate at a 
higher rate than the other isomers. Within the P(-)-iso-
mers, phosphonylation by C(+)P(-)-soman occurs 4- to 7-
fold faster than by C(-)P(-)-soman. This suggests that, 
at sufficiently low dosis, the C(+)P(-)-isomer will under-
go a more rapid biodégradation, due to this irreversible 
binding to serum proteins, as compared with the C(-)P(-)-
isomer. If the same stereoselectivity exists for irrever-
sible binding sites of other tissues, C(-)P(-)-soman could 
be considered to be more toxic, despite its slightly wea-
ker inhibitory potency towards human erythrocyte and brain 
Cholinesterase (De Jong and Kossen, 1985). 
As far as the P(+)-isomers are concerned it can be 
stated that phosphonylation occurs at a rate that is sig-
nificantly different from zero. Due to insufficient mea-
surement precision no further conclusions can be drawn 
with regard to the relative contribution of spontaneous 
hydrolysis on the observed rate constants. 
By combining the values of the phosphonylation rate 
constants of C(+)P(-)- and C(-)P(-)-soman, obtained in 
section V.3.3.2. with the eqn. V-5 and V-6 a relative 
ranking of the four phosphonylation rate constants can be 
calculated (Table V-5). 
TABLE V-5 : Estimated relative contribution by the four 
stereoisomers of soman to phosphonylation of 
human serum proteins determined according to 
the combined approaches described in sections 
V.3.3.1. and V.3.3.2. 
The phosphonylation rate constant by C(-)P(+)-
soman is arbitrarily assigned a value of 1. 
C ( + ) P ( - ) 
18 
C ( - ) P ( - ) 
3 
C( + )P (+ ) 
3 
C ( - ) P ( + ) 
1 
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V.3.4. Identification of the irreversible binding sites in 
human serum. 
When the molar concentrations of irreversible binaing 
sites, found in human serum, are compared with the molar 
concentrations of butyrylcholinesterase in human serum 
Ulyers, 1952), it is seen that the values are within the 
same order of magnitude. Since soman blocks butyrylcholi-
nesterase, this suggests that butyrylcholinesterase is ac-
tually the only source of irreversible binding sites for 
soman (and for other organophosphorus-anticholinesterase 
agents) in human serum. 
It was reported that phosphonylation of butyrylcholineste-
rase by soman and the subsequent aging are stereoselective 
processes (Keijer and Wolring, 1969), both occuring at a 
faster rate for the P(-)-isomers than for the P( + )isoiriers. 
The rapid aging explains the stability of phosphonylated 
serum protein and the stereoselectivity towards 
phosphonylation in human serum was found to be along the 
same lines as that reported for horse serum cholineste-
raserase (Keijer and Wolring, 1969; Nordgren ¿, a-i , 1984) 
I.e. C(+)P(-) > C(-)P(-) > C(±)P(+). 
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CHAPTER VI 
DEGRADATION AND STABILIZATION OF SOMAN IN DOG SERUM 
OR PLASMA. 
VI. 1. INTRODUCTION. 
In chapter II a method was developed which enables 
the detection of soman in serum at a level sufficiently 
low that the degradation of soman at concentrations that 
are expected to occur in severely poisoned mammals can be 
studied. 
As mentioned in chapter I, a kinetic study of soman 
in the experimental animal should make it possible to des-
cribe the distribution and elimination of the toxic agent 
in the body; this knowledge would be of interest to opti-
mize a therapeutic scheme. Although rodents are frequent-
ly used for ¿л v^ i/ü experiments on therapy against soman 
poisoning, the dog is probably a more appropriate species 
for a toxicokinetic study, since a complete concentration-
time curve can easily be established from one animal and 
since some similarities exists with the human species : 
according to Augustinsson (1958), the patterns of serum 
esterases are similar for man and dog, I.e.. their sera 
contain only butylcholinesterase and A-esterase and no 
aliesterase; in this context it may be mentioned that dog 
serum contains about 2/3 of the butyrylcholinesterase of 
an equal volume of human serum (Myers, 1952). 
Before it is possible to attain the final goal of a 
kinetic study ¿si v±.vo of soman plasma concentration елш-і 
time in the dog it is necessary to study the АЛ лЛяо de­
gradation processes of soman in dog plasma (as was done in 
human serum) and to block these processes in a way that is 
compatible with blood sampling, -L.e. hemolysis should be 
avoided. 
This chapter, therefore, mainly concerns the study of 
the essential degradation pathways of soman in dog serum 
and the blocking of them. In a second part the soman 
plasma concentration will be followed as a function of ti-
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me in some severely poisoned dogs. These preliminary 
experiments are included to demonstrate that the method 
developed in this work is suitable for the purpose of a 
kinetic study. Nevertheless, to obtain a sufficient 
capacity of sample handling, the assay described in 
chapter II had to be slightly modified. 
VI.2. MATERIALS AND METHODS. 
V1.2.1. Jn vitno experi ments. 
VI.2.1.1. Dog serum. 
Blood was collected from a venous puncture in a fore­
leg and allowed to clot. After centrifugation (5000 
r.p.m., 10 min), the supernatant was collected : either 
individual sera or pooled sera from three to five dogs 
were stored at - 180C. 
VI.2.1.2. Preincubation. 
Where preincubation is applied, the C(±)P(±)-soman 
concentration used was 0.5 μΜ. 
VI.2.1.3. Degradation experiments and assay. 
The degradation experiments and assays were performed 
as described in chapters II to V. 
VI.2.2. un vivo experiments. 
VI.2.2.1. Reagents. 
2-methylcyclohexyl methylphosphonofluoridate ("compe­
titor") was synthesized in an analogous way to that of 
soman referred to in chapter II; the purity was found to 
be > 95 % by NMR. 
Reverse phase cartridges (50 mg - Π 8 ) were from Ana-
lytichem. Butylacetate was spectroscopic grade; all other 
chemicals used were of analytical grade. 
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V1.2.2.2. Determination of soman plasma concentrations in 
the dog. 
VI.2.2.2.1. Experimental protocol. 
Fasted mongrel dogs of either sex were anaesthetized 
with nembutal (30 mg/kg, i.v.) and a femoral and cephalic 
vein were canulated with polyethylene tubing. The blood 
pressure was monitored. Atropine sulphate (2 mg/kg) was 
injected, followed by C(±)P(±)-soman (100 pg/kg approxi-
mately 10 LD50) intravenously in the foreleg fifteen minu-
tes later. After soman administration the dogs were ven-
tilated via a trachial cánula with room air. Blood samp-
les (2 ml) were drawn from the femoral vein at various ti-
mes after dosing with soman. The sampled blood was added 
to 1 ml of ice-cooled tris buffer solution (pH 5.3), con-
taining EDTA and aluminon (20 mM, each) and 2-methylcyclo-
hexyl methylphosphonofluoridate (2.7 μΜ). After centrifu-
gation (5.000 r.p.m., 5 min) an aliquot of 0.6 to 1.6 ml 
of the supernatant (pH 6.5) was analyzed for soman. 
VI.2.2.2.2. Determination of soman. 
The method described in chapter II was slightly modi­
fied : The amount of reverse phase adsorbent was reduced 
from 350 to 50 mg and consequently the volume of eluent 
could be reduced from 2 to 0.5 ml. To speed up the evapo­
ration step ether was chosen as a cosolvent, in stead of 
benzene or ethylacetate, without noticeable loss in reco­
very. 
To an aliquot of the supernatant internal standard 
was added and the whole was sucked trough a reverse phase 
(C18) cartridge. Elution was done with 0.5 ml of a mixtu­
re of diethylether and butylacetate (85/15, v/v). The 
solvent was concentrated under a nitrogen flow and five 
microlitres were injected splitless into the GLC; the 
chromatographic conditions were slightly modified as com­
pared with chapter II : He was used as a carrier gas with 
an inlet pressure of 405 kPa (73 psi) allowing a shorter 
elution time (^  5 min) without loss in column performance. 
Quantitation was based on the ratios of peak heights of 
soman and internal standard; both soman peaks were 
quantified separately, I.e.. the first peak accounts for 
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C(-)P(+)- and C(+)P(-)-soman, and the second peak for the 
other isomers. Calibration curves were constructed in the 
ranges 5 to 50 ng soman, 0.3 to 5 ng soman, and 0.02 to 
0.5 ng soman respectively. Blank analysis was performed 
on a blood sample that was taken prior to the administra-
tion of soman. 
VI.3. RESULTS AND DISCUSSION. 
VI.3.1. ünvLüio degradation of soman in dog serum. 
VI.3.1.1. Phosphonylation of dog serum proteins. 
Figure VI-1 shows that, analogously to the results 
obtained in human serum ( согі{івл Figure VI-1), the degra­
dation of CU)P(±)-soman in dog serum depends upon the 
initial concentration of soman; this suggests that the de­
gradation of soman in dog serum will comprise phosphonyla-
Figure VI-1 : Degradation of C(±)P(±)-soman in dog serum 
at pH 7.4 and 250C, and at various initial concentrations: 
Δ, 52 nM; A, 104 nM; D, 260 пМ;Я, 520 nM. 
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tion and hydrolysis. Indeed, after preincubation with so-
man, the phosphonylation sites are saturated and a 
biphasic degradation of C(±)P(±)-soman is observed (Figure 
VI-2,·). This biphasic decline may account for the dif-
ference in hydrolysis rates between P(+)- and P(-)-iso-
mers. It is seen that after some 10 minutes, the slow 
parts of the degradation curves become equidistant. In 
the same way as was done for human serum the concentration 
of phosphonylation sites can be determined (Figure VI-2; 
see also Figure V-2). Table VI-1 shows the results for 
two batches of dog serum. It is seen that the mean value 
obtained, 41 nM is in good agreement with the value of 
butyrylCholinesterase concentration in dog serum, ¿.e. 46 
nM (Myers, 1952). Hence it can be tentatively concluded 
that, as in human serum, the phosphonylation sites in dog 
serum are identical with butyrylcholinesterase. 
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Figure VI-2 : Determination of the concentration of 
phosphonylation sites in dog serum. The linear parts of 
the degradation curves (at 250C and pH 7.4) in preincuba-
tes (·) and not-preincubated (O) dog serum are extrapola­
ted to zero minutes. The values obtained are subtracted 
(Ominus 0) and the result (expressed as % of initial con­
centration) is multiplied by the initial concentration of 
C(±)P(±)-soman (208 nM), to obtain the concentration of 
phosphonylation sites. 
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TABLE VI-1 : Concentration of phosphonylation sites (± 95% 
confidence limits) in pooled dog sera. The 
values are measured according to Figure VI-2. 
Pool A Pool В 
Concentration of phospho­
nylation sites (nM) 36 45 ± 12 
< 
S 
о 
M 
о 
ζ 
« 
S 
ш 
100 
10 
χ 
Νν 
6 MIN 
Figure VI-3 : Hydrolysis of C(+)P(±)- and C(-)P(±)-soman 
in preincubated dog serum at pH 7.4 - 7.6 and 250C. Ini­
tial concentration 0.56 μΜ. О- C(+)P(+), #- C(+)P(-), 
Δ- C(-)P(
 +
 ), A- C(-)P(-). 
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V1.3.1.2. Hydrolysis of soman isomers in dog serum. 
In preincubated dog serum a biphasic degradation was 
found for C(±)P(±)-soman (Figure VI-2). Using C(+)P(±)-
and C(-)P(±)-soman, the hydrolysis rate constants of the 
four stereoisomers can be determined (Figure IV-3) : the 
rate constants increase in the following order, C(+)P(-)< 
C(-)P(-) < C(-)P(+) < C(+)P(+). The absolute values for 
some individual dog sera and some pooled sera are given in 
Table VI-2. The relative hydrolysis rates are 1:3.1:30:500 
(calculated from pool 2). From a pool of freshly prepared 
human serum and under identical conditions a similar 
ranking is found, with the relative rates 1:2.6:89:850 
(Table IV-11). 
TABLE VI-2 : Hydrolysis rate constants of the stereoiso­
mers of soman in preincubated (0.5 μΜ 
C(±)P(±)-soman, pH 7.4, 250C, 17 h) dog serum 
at 250C and pH 7.4 - 7.6. 
C(+)P(-) C(+)P(+) C(-)P(+) C(-)P(-) 
Dog 1 
Dog 2 
Dog 3 
Pool 1 
Pool 2 
0.010±0.006 
n.d. 
n.d. 
0.011±0.07 
0.011±0.003 
5.3±2.1 
4.1±1.0 
6.2±1.6 
7.1 b 
5.5±1.4 
0.56±0.05 
0.40±0.11 
0.34±0.06 
0.394 b 
0.33±0.04 
0.068±0.020 
0.030±0.018 
0.036±0.003 
0.045±0.004 
0.034±0.003 
a — 1 
min ; ± 95% confidence interval, 
Determined from two points only. 
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Compared with human serum the global hydrolysis in dog se­
rum shows less stereoselectivity between the P(+)- and 
P(-)-isomers. However, the selectivity ratio of the 
C( + )P( + )- елш<і the C(-)P( + )-isomer is larger in the dog. 
This stereoselective hydrolysis of the P(+)-isomers in dog 
serum suggests an enzymatic mechanism. Therefore the tem­
perature dependence of the hydrolysis of both P(+)-isomers 
was determined (Figure VI-4). From the linear relation­
ship log к = f (1/T) (see also IV.3.1.) the activation 
energies can be calculated (Table VI-3). The values are 
similar to those found for the hydrolysis of the 
P(+)-isomers in human serum. 
MIN' 
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Figure VI-4 : Temperature dependence of hydrolysis rate 
constants of soman in dog serum at pH 7.4. D - C( + )P( + ), 
• - C(-)P{ + ). 
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TABLE VI-3 : Activation energies kJ/mol, ± 95% confidence 
intervals) for the hydrolysis of soman iso-
mers in preincubated dog serum. The values 
are obtained from a plot as shown in Figure 
VI-4. 
C(+)P(+) C(-)P(+) 
32 ± 6 33 ± 6 
VI.3.1.3. Stabilization of soman in dog serum. 
It was previously shown that, in human serum, both 
phosphonylation and hydrolysis are pH-dependent, and 
become almost completely blocked at pH 4 (Figure III- 4). 
A similar stability is found in dog serum (Figure 
VI.4.a.). However, since a low pH in blood may induce 
hemolysis, another way of stabilization of soman had to be 
developed. 
The addition of EDTA and aluminon (10 mM each) gives 
some stability (Figure VI-4.b.), probably by blocking the 
enzymatic degradation in a way analogous to that for human 
serum (see chapter IV). The phosphonylation sites could 
possibly be blocked by adding another organophosphorus 
compound that competes with soman for the reaction with 
the sites. The effect of such a "competitor" is shown on 
Figure IV-4.b. When added in a one hundred-fold excess 
over soman, 2-methylcyclohexyl methylphosphonofluoridate 
effectively occupies the majority of serum phosphonylation 
sites, thereby preventing soman from being degraded this 
way. 
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Figure VI-5 : Stability of C(±)P(±)-soman (55 nM, initial 
concentration in : 
(a) dog serum adjusted at pH 4.0. 
(b) dog serum at pH 7.4 : 
with EDTA aluminon (10 mM) added (D) 
with EDTA and aluminon (10 mM) and 2-methylcyclohexyl 
methylphosphonofluoridate (5.5 nM) added (•) . 
From these results one can anticipate that adding a 
sufficiently concentrated solution of EDTA, aluminon and a 
"competitor" to a blood sample will block further degrada­
tion of soman. 
VI.3.2. On vLvo study of the soman plasma concentrations 
in the dog as a function of time : preliminary 
observations. 
Under the experimental conditions mentioned, the dogs 
survived a challenge of circa 10 LD50 of soman for 150 
minutes without heavy symptoms. Representative decay 
curves for three dogs are shown in Figure VI-6. Part A 
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VI-6 : Fate of soman in the dog; three representative experiments. 
(A) First peak containing C(+)P(-)- and C(-)P(+)-soman. 
(B) Second peak containing C(+)P(+)- and C(-)P(-)-soman. 
shows the decay of the first soman peak, containing the 
C(+)P(-)- and C(-)P(+)-isomers; part В represents the 
decay of the second soman peak, containing the C(+)P(+)-
and 'C(-)P(-)-isomers {сопрел Figure III-l). Although, 
strictly speaking, no conclusions can be drawn from Figure 
VI-6 concerning individual isomers, it is tempting to 
speculate that in both parts the contribution of the 
corresponding P(+)-isomers will rapidly become in­
significant due to the fast enzymatic hydrolysis; then, 
after a few minutes, the concentration shown should be 
mainly those of the C(+)P(-)-isomer (part A) and of the 
C(-}P(-)-isomer (part B). The curves of both C(-)-isomers 
could then be fitted to a multi-compartment model : the 
calculation of model parameters and their interpretation 
in terms of distribution and elimination will not be 
performed from these preliminary curves, also because each 
of the chromatographic peaks possibly is composed of two 
isomers and the rapid -m v^vo disappearance of the P( + )-
isomers has not been formally proven. 
VI.4. CONCLUSIONS. 
It was shown in this chapter that soman behaves in 
dog serum under іл лАло conditions almost as in human se­
rum : the degradation processes comprize mainly phosphony-
lation and hydrolysis. Since the concentrations of 
phosphonylation sites and of butyrylcholinesterase in dog 
serum are found to be within the same order, the phospho­
nylation sites are tentatively identified as butyrylcholi­
nesterase. Hydrolysis is a stereoselective process; the 
rate constants are ranked in a similar way as for human 
serum ¿.е., C(+)P(+) > C(-)P(+) > C(-)P(-) > C(+)P(-); the 
absolute values of the rate constants however are diffe­
rent from those in human serum. The hydrolysis is nearly 
completely stopped by adjusting the pH of the serum at pH 
4 or by adding a solution of EDTA/Aluminon. For the pur­
pose of an Ы v-Lvo kinetic study in the dog, blood samples 
can be "stabilized" with regard to soman degradation by 
adding a solution of EDTA, aluminon and a "competitor" 
(2-methylcyclohexyl phosphonofluoridate), the latter com­
pound competes with soman for possible remaining phospho­
nylation sites. 
A preliminary determination of plasma concentrations of 
soman after administration of 10 LD50 in the dog indicates 
that the kinetics might be described by a multi-compart­
ment model. 
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SUMMARY 
Intoxications by organophosphorus insecticides and 
nerve agents were previously considered to be a "hit and 
run" phenomenon, L· e. part of an administered dose will 
serve to inhibit acetylcholinesterase and the remaining 
part will be eliminated quickly from the organism. A cau-
sal therapy therefore only aimed a reactivation of inhibi-
ted acetylcholinesterase. A subsequent reinhibition due 
to non-eliminated toxic agent was not considered. A toxi-
cokinetic study of the insecticide parathion showed that 
parathion was found in plasma several days after severe 
intoxication. At about the same time similar facts were 
reported for the nerve agent soman : several hours after 
administration of 6xLD50 to atropinized and anaesthetized 
rats anticholinesterase activity was still found in the 
blood, sufficient for reinhibition of Cholinesterase that 
might have been reactivated . These findings showed that 
a causal therapy of a severe intoxication cannot be 
restricted to an unique administration of the antidote but 
that this should be repeated during some time. For the 
characterisation of this time factor a toxicokinetic study 
of soman is needed. 
Prior to the study of the toxicokinetics of soman in 
the experimental animal a method for the assay of low so-
man concentrations in plasma had to be developed. In ad-
dition to the problems normally encountered when determi-
nations have to be performed close to the detection limit, 
the following complications show up : (1) The molecule so-
man contains two asymmetric centres and therefore consist 
of four stereoisomers. The spatial arrangement around an 
asymmetric centre causes a rotation of a polarized light 
beam in either ( + )- or (-)-sense. The mixture of four 
isomers therefore is indicated as C(±)P(±), and the four 
individual isomers as C(+)P(-), C(+)P(+), C(-)P(+) and 
C(-)Pf-) (Fig 1-2). Since these isomeric forms have a 
different biological activity, the analytical method 
should allow to distinguish, either directly or indirectly 
between the four isomers. (2) From the literature it can 
be expected that soman will be degraded in blood according 
to various pathways, that all have to be blocked at the 
time of sampling. Moreover, since we want to quantify 
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plasma levels, our inhibition method must not induce 
haemolysis. It is further useful to expand on the bio-
degradation of soman in plasma or serum for fundamental 
reasons, also because these processes partially reflect 
reactions that occur in vi.vo. 
In this dissertation the problems related to the 
quantitative determination of low soman concentrations in 
plasma or serum are studied. The technique realised is 
then applied for the study of the biodégradation of soman, 
largely limited to іл іЛло investigations in the sera and 
plasma of the dog, the experimental animal chosen, and of 
man, whereto the in. vivo results are to be extrapolated. 
The thesis is presented as follows : 
In Chapter II a method is developed that allows the 
determination of soman at the level of some tens of pico-
grams per milliliter of aqueous solution. The assay is 
based upon the extraction of soman by means of an octade-
cyl-modified silica. After an elution/ concentration step 
the analysis is done with gas chromatography using split-
less injection into a capillary column and NP-detection. 
The determination limit is better than 40 pg/ml. The 
achiral chromatography we used, only allows the separation 
of the diastereoisomers (Fig II-l). If C(+)P(±)- or 
C(-)P(±)-soman is used, however, one single peak corres­
ponds to one isomer. In the case of C( ±)P( ±)-soman the 
determination of the kinetic parameters of the isolated 
isomers was possible because of a clearcut difference in 
their kinetic behaviour. 
In Chapter III it is shown that the degradation of 
C(±)P(±)-soman in human serum is composed mainly of two 
processes : (1) an irreversible binding to proteins; this 
binding also occurs with other organophosphates that have 
a good leaving group. Preincubation with an adequate or-
ganophosphate allows the saturation of these binding si­
tes. (2) A series of degradation processes that, accor­
ding to the literature, can be considered as hydrolysis. 
A distinction can be made between : (a) hydrolysis cataly­
sed by one or more proteins having a molecular weight 
greater than 100,000, stereoselectively catalysing the hy­
drolysis of the P(f)-isomers. This stereoselectivity 
allows the cajculation of individual hydrolysis rate 
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constants starting from C(±)P(±)-soman. (b) The global 
effect of the remaining hydrolysis processes is evaluated 
from experiments in serum-ultrafiltrate. 
In Chapter IV the hydrolysis processes in human serum 
are further investigated using the half-resolved C(+)P(±)-
and C(-)P(±)-soman. The spontaneous hydrolysis is estima­
ted from experiments in buffer solutions; a difference in 
hydrolysis rate was detected between the diastereoisomers. 
A catalytic effect is found in serum fractions IV and V 
(albumin). The contributions, however, are negligible as 
compared with the stereoselective hydrolysis of the P(+)-
isomers due to the activity of one or more phosphoryl-
phosphatase enzymes ( •іоталаіе ) . This reaction is also 
characterized by an important lowering in activation ener­
gy as compared with the spontaneous hydrolysis of the four 
isomers in buffer and with the hydrolysis of the P(-)-iso-
mers in plasma and serum. In addition the stereospecific 
enzymatic hydrolysis is inhibited by Hg -ions, that do 
not influence the hydrolysis of the P(-)-isomers, however. 
The possible conclusions are, that either the P(-)-isomers 
are not at all hydrolyzed by mmana-ie., or at least, that 
the mechanism of the P(-)-hydrolysis fundamentally differs 
from the mechanism of the P(+)-hydrolysis. In this chapter 
the inhibition of the hydrolytic processes is also stu­
died. In agreement with the observations on the hydroly­
sis of paraoxon in human plasma a nearly complete inhibi­
tion is found when a combination of EDTA and aluminon is 
added to serum or plasma. The inhibition disappears when 
Ca -ions are added, suggesting that calcium-ions act as a 
co-factor of ιοηκυιαιβ. . On the basis of various reports 
one might also expect some inhibition of -iomana^e. upon ad­
dition of specific metal ions, but under the experimental 
conditions described in this thesis such an effect was not 
found. Finally the influence of pH on the hydrolysis of 
both P(+)-isomers was studied. The pH-dependency differs 
for the two isomers; this may suggest that more than one 
type of wmanaie. is involved in the enzymatic hydrolysis. 
The saturable binding of soman to human serum or 
plasma proteins (phosphonylation) is studied in Chapter V. 
The stability of the binding in time is demonstrated and 
the concentration of binding sites is determined. A good 
correlation exists with the concentration of butyrylcholi-
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nesterase in serum. No difference is found between the 
concentrations of binding sites in plasma and serum. The 
stereoselectivity of the phosphonylation reaction is also 
determined : the C(+)P(-)-isomer phosphonylate at a higher 
rate than the other isomers. 
In Chapter VI the biodégradation of soman is studied 
in canine serum and plasma. Phosphonylation and hydroly-
sis are the main processes found ¿n vLt/io , in agreement 
with observations in human serum and plasma. Since the 
concentration of the binding sites in dog serum and plasma 
also corresponds with the concentration of butyrylcholi-
nesterase, it can be presumed that phosphonylation sites 
are identical with butyrylcholinesterase. In dog serum 
and plasma too, hydrolysis is found to be a stereoselec-
tive process, favouring the P(+)-isomers and with a 
ranking for the four isomers similar to that reported in 
human serum. The hydrolysis is also blocked by adding EDTA 
and aluminon. Hence it is possible to adequately sta-
bilize blood samples taken for an ¿a vÁ.vo kinetic study : 
EDTA and aluminon will block the hydrolysis and 
phosphonylation by soman will be inhibited through the 
addition of a "competitor", a compound with a similar 
structure to that of soman and thus competing with soman 
for the occupation of remaining sites. A preliminary 
determination of soman plasma concentrations after 
administration of about lOxLDSO in the aog was performed. 
The results show that the kinetics can probably be 
described by a multi-compartmental model. 
126 
SAMENVATTING 
Intoxicaties door zenuwgassen en organofosfaat-insec-
ticiden werden vroeger aanzien als een "hit and run" feno-
meen, d.w.z. dat, bij een gegeven dosis, een deel van het 
toxicum zal dienen voor de inhibitie van acetylcholineste-
rase terwijl het overige snel uit het organisme wordt ge-
ëlimineerd. Een causaal therapeutisch schema was dan ook 
tot nu toe gericht op het eenmalig reactiveren van het ge-
inhibeerde acetylcholinesterase. Met een later optredende 
reïnhibitie, te wijten aan niet-geëlimineerd toxicum werd 
geen rekening gehouden. Een toxicokinetische studie van 
het insecticide parathion liet toe aan te tonen dat para-
thion gedurende meerdere dagen na zware intoxicatie in het 
plasma kon worden teruggevonden. Omstreeks dezelfde tijd 
werden gelijkaardige vaststellingen gerapporteerd m.b.t. 
het zenuwgas soman : na toedienen van 6xLD50 aan 
geatropiniseerde ratten werd na meerdere uren nog anticho-
linesterase-aktiviteit teruggevonden in het bloed, vol-
doende voor reïnhibitie van eventueel gereactiveerd Choli-
nesterase. Deze feiten tonen aan dat causale therapie bij 
zware vergiftigingen niet als een eenmalige behandeling 
mag worden beschouwd, maar integendeel gedurende zekere 
tijd dient te worden voortgezet. Het karakteriseren van 
deze tijdsfactor in de causale therapie vereist een toxi-
cokinetische studie van soman, tegelijk met het bepalen 
van een toxicologisch significante plasmaconcentratie. 
Om de toxicokinetiek van soman in het proefdier te 
kunnen bestuderen moet in de eerste plaats een methode 
voor de bepaling van lage somanconcentraties in plasma 
worden uitgewerkt. Naast de problemen, inherent aan bepa-
lingen in het domein van de detectielimiet, treden nog 
volgende complicaties op : (1) De molecule soman bevat 
twee asymmetrische centra en bestaat dus uit vier isome-
ren. De ruimtelijke schikking rond een asymmetrisch cen-
trum geeft aanleiding tot een rotatie van gepolariseerd 
licht in de (+)- pf (-)-zin. Het mengsel van de vier iso-
meren van soman wordt aangegeven als C(±)P(±),de vier iso-
meren afzonderlijk als C(+)P(-), C(+)P(+), C(-)P(+) en 
C(-)P(-), respectievelijk (Fig. 1-2). Gelet op het ver-
schil in biologische activiteit tussen deze vier vormen 
moet de methode toelaten, hetzij direct, hetzij indirect 
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de vier isomeren te bepalen. (2) Uit het literatuuronder-
zoek kan worden afgeleid dat soman in bloed onderhevig is 
aan degradatieprocessen, die moeten worden geblokkeerd op 
het ogenblik van de monstername. Deze remming moet bij 
voorkeur zodanig gebeuren dat hémolyse wordt vermeden, om 
na centrifugeren de bepaling van soman in plasma te kunnen 
uitvoeren. Om fundamentele redenen is het nuttig dieper 
in te gaan op deze biodegradatie in plasma of serum, ook 
omdat deze processen een partiële weerspiegeling is van ¿n. 
vJ-vo optredende reacties. 
Deze thesis bestudeert de problematiek van de kwanti-
tatieve bepaling van lage soman-concentraties. De uitge-
werkte techniek wordt gebruikt in de studie van de biode-
gradatie van soman maar dan grotendeels beperkt tot -in. vi.-
іла onderzoek in sera en plasma van de hond, het gekozen 
proefdier, en van de mens, tot dewelke uiteindelijk de -Ln. 
vi.vo resultaten in de hond moeten worden geëxtrapoleerd. 
Het werk is als volgt ingedeeld : 
In Hoofdstuk II wordt een methode ontwikkeld, die 
toelaat soman te bepalen tot het niveau van tientallen pi-
cogram per milliliter. De bepaling is gebaseerd op ex-
tractie van het soman uit het waterig midden met behulp 
van een met octadecylgroepen gemodificeerd silica. Na een 
elutie/concentratie stap wordt de analyse uitgevoerd 
d.m.v. capillaire gaschromatografie met "splitless" injec-
tie en NP-detectie. De bepalingsiimiet is beter dan 40 
pg/ml. De achirale chromatografie laat enkel de scheiding 
van de diastereoisomeren toe (Fig. II-l). Indien echter 
C(+)P(±)- of C(-)P(±)-soman wordt gebruikt, stemt één piek 
overeen met één isomeer. In het andere geval kan de 
scheiding enkel gebaseerd zijn op een sterk verschil in 
kinetisch gedrag. 
In Hoofdstuk III wordt aangetoond dat de degradatie 
van C(±)P(±)-soman in humaan serum bestaat uit hoofdzake-
lijk twee processen : (1) Een satureerbare binding aan 
proteïnen. Deze binding blijkt ook op te treden in geval 
een ander organofosfaat met goede "leaving group" wordt 
gebruikt. Preïncubatie met een geschikt organofosfaat 
laat toe om deze binding te verzadigen. (2) Een reeks de-
gradatieprocessen die, op basis van literatuurgegevens, 
als hydrolyse kunnen worden bestempeld. Er kan een onder-
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scheid worden gemaakt tussen : (a) een hydrolyse, gecata-
lyseerd door één of meerdere proteïnen met moleculaire 
massa groter dan 100.000, met een stereoselectief effect 
in het voordeel van de P(+)-isomeren; dit stereoselectief 
effect laat trouwens toe de individuele snelheidsconstan-
ten te berekenen. (b) De resterende hydrolyseprocessen, 
waarvan het totaaleffect wordt geëvalueerd via experimen-
ten in serum-ultrafiltraat. 
In Hoofdstuk IV worden de hydrolyseprocessen verder 
onderzocht aan de hand van het half-geresolveerde 
C(+)P(±)- en C(-)P(±)-soman. De "spontane" bijdrage wordt 
geëvalueerd aan de hand van experimenten in bufferoplos-
singen; tussen diastereoisomeren wordt een verschil in hy-
drolysesnelheid gedetecteerd. Een catalytisch effect 
wordt gevonden in serumfracties IV en V (albumine). Deze 
bijdragen zijn echter verwaarloosbaar ten opzichte van de 
stereoselectieve hydrolyse van de P(+)-isomeren, te wijten 
aan de activiteit van één of meerdere fosforylfosfatase 
enzymen (•зотапа-зе. ). Deze reactie wordt trouwens geken­
merkt door een merkelijke verlaging in activeringsenergie 
in vergelijking met de spontane hydrolyse van de vier iso­
meren in buffer en met de hydrolyse van de P(-)-isomeren 
in plasma en serum. De stereospecifieke enzymatische hy­
drolyse wordt bovendien geremd door Hg -ionen, die echter 
geen invloed hebben op de hydrolyse van de P(-)-isomeren. 
Dit leidt tot de conclusie dat, ofwel de P(-)-isomeren 
niet worden gehydrolyseerd door wmanaie , ofwel het me­
chanisme van de P(-)-hydrolyse fundamenteel verschilt van 
dat van de P( + )-hydrolyse. In dit hoofdstuk wordt ook de 
remming van de hydrolytische processen bestudeerd. Net 
zoals voor de afbraak van paraoxon in humaan plasma wordt 
een nagenoeg volledige remming van de hydrolyse van soman 
bekomen door een combinatie van EDTA en aluminon. Deze 
remming wordt opgeheven door toevoegen van Ca++-ionen, wat 
de rol van calcium-ionen als co-factor naar voor schuift. 
Op basis van de literatuur kon eventueel ook een zekere 
remming worden verwacht door toevoegen van bepaalde me­
taal-ionen, maar dit effect werd niet vastgesteld voor 40-
mana-ie. onder de beschreven experimentele voorwaarden. 
Tenslotte werd ook de invloed nagegaan van de pH op de 
hydrolyse van de beide P(+)-isomeren. De pH-afhankelijk-
heid is verschillend voor beide isomeren; dit kan erop 
129 
wijzen dat meer dan één type -iomana-ie betrokken is in de 
enzymatische hydrolyse. 
De satureerbare binding van soman aan serum- of plas-
maproteïnen (fosfonylering) wordt bestudeerd in Hoofdstuk 
V. De stabiliteit van de binding in de tijd wordt aange-
toond en de concentratie aan bindingsplaatsen wordt be-
paald. Zij blijkt goed overeen te stemmen met de serum-
concentratie van butyrylcholinesterase. Tussen plasma en 
serum treedt geen enkel verschil op. De stereoselectivi-
teit van de fosfonyleringsreactie wordt eveneens nage-
gaan : de C(+)P(-)-isomeer vertoont veruit de hoogste 
fosfonyleringssnelheid. 
In Hoofdstuk VI wordt de biodegradatie van soman be-
studeerd in hondenserum en -plasma. Net zoals voor de 
mens worden ook hier ¿л. іЛло hoofdzakelijk fosfonylering 
en hydrolyse teruggevonden. Vermits de concentratie bin­
dingsplaatsen in hondenserum en -plasma overeenstemt met 
die van butyrylcholinesterase kan, net zoals voor de mens, 
worden vooropgesteld dat de fosfonyleringspiaatsen en het 
butyrylcholinesterase identiek zijn. Ook in hondenserum 
en -plasma is de hydrolyse een selectief proces in het 
voordeel van de P( + )-isomeren en met een rangorde die, 
voor de vier isomeren, overeenstemt met die welke is ge­
vonden in humaan serum. De hydrolyse wordt eveneens ge­
blokkeerd door toevoegen van EDTA en aluminon. Het is dan 
ook mogelijk om bloedmonsters, genomen ter gelegenheid van 
een іл vLvo kinetische studie, adekwaat te stabilizeren : 
voor de remming van de hydrolyse worden EDTA en aluminon 
toegevoegd, terwijl de fosfonylering wordt afgeremd door 
een"competitor" in honderdvoudige overmaat toe te voegen; 
deze laatste stof is een organofosfaat met een gelijkaar­
dige structuur van soman, waarmee ze in competitie treedt 
voor het bezetten van overgebleven bindingsplaatsen. Een 
preliminaire bepaling van plasmaconcentraties van soman, 
na toedienen van ongeveer lOxLDSO aan de hond wordt be­
schreven. Uit de resultaten blijkt daL de kinetiek waar­
schijnlijk door middel van een multi-cornpartimenteel model 
kan worden beschreven. 
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RESUME 
Les intoxications par gaz neurotoxiques et insectici-
des organophosphorés étaient considérées jadis comme des 
phénomènes de "hit and run", c.à.d. qu'une partie de la 
dose administrée sert à l'inhibition de 1'acetylcholines-
terase, l'autre partie du toxique étant éliminée rapide-
ment de l'organisme. Un schéma thérapeutique causal avait 
jusqu'à présent pour but la réactivation unique de 1'ace-
tylcholinesterase inhibée, ne tenant pas compte d'une ré-
inhibition ultérieure due au toxique non-éliminé. Une 
étude toxicocinétique de l'insecticide parathion a permis 
de démontrer la persistance du parathion dans le plasma 
pendant plusieurs jours après une intoxication grave. Des 
constatations semblables ont été rapportées concernant le 
neurotoxique soman : après l'administration d'une dose de 
6xLD50 à des rats atropinises, on a détecté pendant 
plusieurs heures de l'activité anti-cholinestérasique dans 
le sang, suffisamment pour causer une réinhibition de la 
Cholinesterase réactivée. Ces faits démontrent que la 
thérapeutique causale d'une intoxication grave ne peut pas 
être considérée comme un traitement unique, mais doit être 
maintenue pendant quelque temps. La caractérisation de ce 
facteur temps dans la thérapeutique causale nécessite une 
étude toxicocinétique du soman, en même temps que la dé-
termination de la concentration plasmatique qui est toxi-
cologiquement significative. 
Afin de pouvoir étudier la toxicocinétique chez 
l'animal, une méthode pour la détermination de faibles 
concentrations de soman dans le plasma doit être mise au 
point. En plus des problèmes inhérents à la détermination 
dans le domaine de la limite de détection d'autres 
complications apparaissent : (1) la molécule de soman 
contient deux centres asymétriques et se compose donc de 
quatre isomères. L'arrangement spatial autour d'un centre 
asymétrique provoque une rotation de la lumière polarisée 
dans le sens ( + ) ou (-). Le mélange des quatre isomères 
est désigné comme C(±)P(±), les quatre isomères séparément 
comme C(+)P(-); C(+)P(+)f C(-)P(+) et C(-)P(-), 
respectivement. Vu la différence en activité biologique 
entre ces quatre formes, la méthode doit permettre de 
déterminer, soit directement, soit indirectement les 
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quatre isomères. (2) L'étude de la littérature permet la 
conclusion que le soman dans le sang subit des processus 
de dégradation, qui doivent être bloqués au moment de 
l'échantillonnage. Ce blocage ne devrait pas provoquer 
d'hémolyse afin de pouvoir déterminer après centrifugation 
la concentration du soman dans le plasma. Pour des 
raisons fondamentales il est utile d'étudier plus en 
détail cette biodégradation dans le plasma ou le sérum 
mais aussi parce que ces processus reflètent partiellement 
les réactions se passant in vivo. 
Cette thèse étudie la problématique de la détermination 
quantitative de faibles concentrations sériques de soman. 
La technique qui est mise au point est appliquée à l'étude 
de la biodégradation du soman, limitée en majeure partie à 
l'étude in vi&w sur serum et plasma de chien, choisi com-
me animal d'expérience, ainsi que sur sérum et plasma 
humain. Les résultats obtenus in vivo chez le chien seront 
finalement extrapolés à l'homme. La thèse est répartie 
comme suit : 
Au Chapitre II une méthode est mise au point permet-
tant la détermination du soman jusqu'au niveau de dizaines 
de picogrammes par millilitre. Cette détermination est 
basée sur l'extraction du soman du milieu aqueux au moyen 
de gel de silice modifiée par des groupements octadecyls. 
Après élution/concentration l'analyse est terminée par 
Chromatographie en phase gazeuse capillaire avec injection 
totale de 5 μΐ et détection sélective (NP). La limite de 
détermination est inférieur à 40 pg/ml. La Chromato-
graphie achirale ne permet que la séparation des dia-
stéréoisomères (Fig. 1-2). Si l'on emploie le C(+)P(±)-
ou le C(-)P( ±)soman, un seul pic correspond à un seul 
isomère. Dans l'autre cas la séparation complète ne peut 
être basée que sur une différence marquée du comportement 
cinétique. 
Au Chapitre III il est démontré que la dégradation du 
C(±)P(±)-soman dans le serum humain se compose principale-
ment de deux processus : (1) Une liaison saturable avec 
des protéines; cette liaison existe aussi pour d'autres 
organophosphorés pourvu qu'ils soient dotés d'un bon "lea-
ving group". Une préincubation avec un composé organo-
phosphoré adéquat permet de saturer cette liaison. (2) 
Une série de processus de dégradation qui, sur base des 
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données de la littérature, peuvent être considérés comme 
une hydrolyse. On peut distinguer : (a) une hydrolyse ca-
talysée par un ou plusieurs types de protéines ayant une 
masse moléculaire supérieure à 100.000 et avec un effet 
stéréosélectif en faveur des isomères P(+); cet effet 
stéréosélectif permet d'ailleurs de calculer les constan-
tes de vitesse individuelles. (b) Les processus d'hydro-
lyse restants dont la contribution totale est évaluée par 
des expériences sur du sérum ultrafiltré. 
Au Chapitre IV les processus d'hydrolyse sont étudiés 
plus en détail à l'aide de soman semi-résolu, c.à.d. le 
C(+)P(±)- et le C(-)P(±)-soman. La contribution spontanée 
est évaluée par des expériences en solutions-tampons; en-
tre les diastéréoisomères une différence de vitesse d'hy-
drolyse est détectée. Un effet catalytique est trouvé 
dans les fractions sériques IV en V (albumine). Toutefois 
ces contributions sont négligeables en comparaison à l'hy-
drolyse stereoselective des isomères P(+), attribuable à 
l'activité d'un ou plusieurs enzymes du type phosphoryl-
phosphatase ( -іоталаіе ) . Cette dernière réaction est 
d'ailleurs caractérisée par une diminution marquée en 
énergie d'activation comparée avec celle de l'hydrolyse 
spontanée des quatre isomères en solution-tampon et l'hy-
drolyse des isomères P(-) dans du plasma ou du sérum. De 
plus l'hydrolyse stéréospécifique enzymatique des isomères 
P( + ) est inhibée par des ions Hg , qui par contre n'in-
fluencent pas l'hydrolyse sérique ou plasmatique des iso-
mères P(-). Ceci nous mène à la conclusion suivante : ou 
bien les isomères P(-) ne sont pas hydrolyses par la -ioma-
αα-ίβ. , ou bien le mécanisme de l'hydrolyse des isomères 
P(-) par la -зотапа^е. diffère fondamendalement de l'hydro-
lyse des isomères P(+). Dans ce chapitre l'inhibition de 
l'hydrolyse est également étudiée. Comme pour la dé-
gradation du paraoxon dans le plasma humain, une inhibi-
tion pratiquement complète de l'hydrolyse du soman est ob-
tenue par une combinaison d'EDTA et d'aluminon. Cette in-
hibition redisparaît après addition d'ions Ca , ce qui 
illustre le rôle des ions calcium comme co-facteur possi-
ble de la -iomana-ie.. Se basant sur la littérature une in-
hibition partielle peut être attendue par l'addition de 
certains ions métalliques, mais cet effet n'est pas con-
staté pour la оотапа-зе. dans les conditions expérimentales 
mentionnées. Finalement l'influence du pH sur l'hydrolyse 
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des deux isomères P( + ). La dépendance du pH n'est pas 
identique pour les deux isomères, ce qui peut indiquer que 
plus d'un type de -iomana-ie. participe à l'hydrolyse enzyma-
tique. 
La liaison saturable du soman au protéines sénques 
ou plasmatiques (phosphonylation) est étudiée au Chapitre 
V. La stabilité de la liaison au cours du temps est dé-
montrée et la concentration en sites liants est détermi-
née. Elle semble être identique à la concentration sén-
que de la butyrylcholinestérase. Entre le plasma et le 
sérum il n'est pas détecté de différence. La stéréosélec-
tivité de la réaction de phosphonylation est également 
étudiée : l'isomère C(+)P(-) possède de loin la plus gran-
de vitesse de phosphonylation. 
Au Chapitre VI la biodégradation du soman est étudiée 
dans le sérum et le plasma de chien. Comme chez l'homme 
on retrouve des phénomènes compatibles avec une phosphony-
lation et une hydrolyse. Puisque la concentration en si-
tes liants dans le sérum et le plasma de chien correspond 
à celle de la butyrylcholinestérase on peut, comme pour 
l'homme, supposer que les sites et la butyrj'lcholinestéra-
se sont identiques. Dans le sérum et le plasma de chien 
l'hydrolyse est un procédé stéréosélec*xf en faveur des 
isomères P(+) et avec un ordre qui, рош les quatre isomè-
res, correspond avec celui trouvé dans le sérum humain. 
L'hydrolyse est également bloquée par l'addition d'EDTA et 
d'aluminon. Il est donc possible de stabiliser adéquate-
ment des échantillons de sang, pris à l'occasion d'une 
étude cinétique JJI V^VO : afin d'inhiber l'hydrolyse, EDTA 
et aluminon sont ajoutés, tandis que la phosphonylation 
est saturée par l'addition d'un "compétiteur" en excès 
d'environ cent fois; cette dernière substance est un 
o ganophosphore ayant une structure semblable à celle du 
soman, avec qui il entre en '-onpétition pour l'occupation 
des sites restants. _а détermination préliminaire de con-
centrations plasmatiques ae sanan après rdministration d'à 
peu près lOxLDSO à des chiens est décrite. Les résultats 
montrent que la cinétique peut probableinent être décrite 
par un modèle multi-compartimental. 
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Bisschop, H.C.J.V.de 
Biodegradation of 
1,2,2-trimethyIpropyleethyIphoephonofluoridate(soman) 
ERRATA 
p. V., line 12, 
from the bottom change critial into : critical 
0 
II 
p. XI DFP correct formula is : F - Ρ - 0CH(CH,), 
OCHtCH,), 
p. XII Sarin correct formula is : F - Ρ - 0CH(CH,)2 
CH, 
p. 9, line 2, 
from the bottom change from into : From 
p. 24, line 16 delete : to 
p. 28, line 26 after dichloromethane delete : . , 
add : and 
change : Subsequently into : 
subsequently 
p. 34, line 5 after manually, add : controlled 
p. 44, line 4, 
from the bottom change ng/100 ml to mg/100 ml 
p. 54, line 12 change epimers into : enantiomers 
line 21 after eluting, add : peaks 
line 22 change claerly into : clearly 
line 25 after decreasing, add : pH 
line 26 delete : no 
- 2 -
p. 55, line 2 delete : by 
p. 76, line 5 change • into # 
p. 82, line 12, 
from the bottom change This into : These 
p. 83, line 1 change table IV-6 into : table IV-7 
line 11 change IV-4 into : IV-1 
line 11 change (figure IV-6) into: (figure IV-4) 
line 13 change IV-8 into : IV-3 
p. 84, line 8, 
from the bottom change attribuable into : 
attri butable 
p. 92, line 12 change C(+)P(-) into : C(-)P(+) 
p. 93, line 12, 
from the bottom change nM into : mM 
line 7, 
from the bottom change exist into : have any 
influence 
p. 98, line 9, 
from the bottom change tainly into : tainty 
p. 101, line 14 delete : /or 
p. 102, line 9 change s. and s2 into : S·. and S» 
p. 103, line 1 change C(-)P(±)- and C(-)P(±)-soman 
into: C( + )P(±)- and C(-)P(±)-sonian. 
p. 104, line 24 change VI-6 into : V-5. 
- 3 -
p. 119, line 13 change VI.4.a. into : VI-5.a. 
line 17 change VI-4.b. into : VI-5.b. 
line 23 change IV-4.b. into : VI-5.b. 
change 5.5 nM into : 5.5 μΜ 
after aimed, add : at 
p. 120, line 7 
p. 123, line 6 
p. 127, line 6, 
from the bottom change £f into : of 
p. 128, line 9 change is into : zijn 
p. 142, line 16, 
from the bottom change Bisdisposition into: 
Biodi spositi on 



STELLINGEN 
1. De enzymatische hydrolyse van de weinig toxische 
P(+)-isomeren van soman in mensenserum treedt niet 
op voor de zeer toxische P(-)-isomeren. 
Dit proefschrift. 
2. De fosfonylering door soman van butyrylcholineste-
rase in mensenserum is een stereoselectief proces : 
de C(+)P(-)-isomeer vertoont veruit de hoogste 
fosfonyleringssnelheid. 
Dit proefschrift. 
3. Soman, toegediend in voldoende hoge dosis, antago-
neert de uitgestelde neuropatische effecten, geïn-
duceerd door bv. diisopropyl fosforfluoridaat. 
M.K. Johnson, J.L. Hillees, H.C. Oe Bisschop, O.J. 
Read and H.P. Benschop, Fund. Appi. Toxicol., 5, 
S180-S181 (19Θ5). 
4. Bij bepaalde ziektetoestanden kan de mate van 
serumbinding van sommige farmaca dermate veranderen 
dat het beoogde farmacologisch effect merkbaar 
wordt beïnvloed. 
F.H. Belpaire, H.G. Bogaert, P. Hugabo and N.T. 
Rosseel, Br. J. Pharmacol., 88, 697-705 (1986). 
5. Dahl e¿ a-L komen voorbarig tot de conclusie dat 
methylfluorofosfonzuur een belangrijke cholineste-
raseremmende activiteit bezit. 
A.R. Dahl, C.H. Hobbs and T.C. Marshall, Toxicol. 
Appi. Pharmacol., 84, 561-566 (1986). 
6. De conclusie van Clement dat aliesterase in de muis 
depot-eigenschappen bezit voor soman, is aanvecht-
baar. 
J.G. Clement, Biochen. Pharmacol., 31, 4085-4088 
(1982). 
7. De verklaring die Grob geeft voor de "solvent trap­
ping" in de gaschromatografie gaat niet op voor be­
paalde gevallen van isotherme elutie. 
K. Grob, Jr., J. Chroiatogr. , 251, 235-2ί>8 (1982). 
8. De identificatie van de stereoisomeren van soman 
door Singh e¿ aU.. is niet correct. 
Α.К. Singh, R.J. Zeleznikar, Jr. and L.R. Drewes, 
J. ChroBatogr., 324, 163-172 (1985). 
9. Het introduceren van atoom- en molecuulorbitalen 
zonder dat de quantummechanische basis voorhanden 
is kan gemakkelij'k leiden tot begripsverwarring. 
10. In het kader van de verificatie van beschuldigingen 
van het gebruik van chemische wapens is de patiënt 
actueel van weinig nut voor de identificatie van 
het chemisch strijdmiddel. 
11. Het voortdurend inzetten van chemische wapens in de 
Golfoorlog kan het tot stand komen van een wereld-
wijd verbod betreffende dergelijke wapens op de 
helling plaatsen. 
Nijmegen-Vilvoorde, 29 october 1986. 
H.C.J.V. De Bisschop 


